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Abstract
Among women in the United States, breast cancer is the second most commonly
diagnosed cancer and is the second-leading cause of death (American Cancer Society,
2015b). A subgroup of women with genetic mutations called BRCA1/2 mutations are at a
significantly higher lifetime risk of developing breast cancer, among other cancers
(Friedman, Sutphen, & Steglio, 2012). While the research base is growing with regard to
women with BRCA1/2 mutations, little is known about the psychological experience of
having a BRCA1/2 mutation and the challenges and obstacles that having a BRCA1/2
mutation entails throughout the lifetime. This study looked at women with BRCA1/2
mutations who had undergone a prophylactic bilateral mastectomy compared to women
who had chosen to undergo surveillance methods only to manage their breast cancer risk.
It was hypothesized that women who had undergone a prophylactic bilateral mastectomy
would display greater experiences of stigma, greater experiences of vulnerability, and
fewer mastery experiences, as well as would rate higher on investment in appearance and
investment in body integrity, when compared to women who had not undergone a
prophylactic bilateral mastectomy and only underwent surveillance methods. Participants
in this study included women who had tested positive for a deleterious BRCA1/2
mutation who spoke and understood English and were older than the age of 18 years.
These women completed an online survey that asked demographic questions, as well as
questions about body image and self-concept. Two separate MANOVAs were conducted
to analyze the results. No significant differences were found between groups. The
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implications of these findings are discussed, as well as limitations of the study and the
need for more research on this area of study.
Keywords: BRCA mutations, BRCA1, BRCA2, self-concept, body image
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Chapter 1: Introduction
Statement of the Problem
Among women, breast cancer is the second most commonly diagnosed cancer and
is the second-leading cause of death (American Cancer Society, 2015b). In 2015,
approximately 234,190 new cases of breast cancer were diagnosed, and approximately
40,730 deaths from breast cancer occurred (American Cancer Society, 2015b).
Approximately 10 to 15% of all cases of breast cancer are the result of genetic
predisposition, with the most common genetic predispositions being mutations on the
BRCA1 and BRCA2 genes (Lux, Fasching, & Beckmann, 2006; Pruthi, Gostout, &
Lindow, 2010). The BRCA1/2 genes are human genes that produce tumor suppressor
proteins, which help repair damaged DNA (American Cancer Society, 2015a). When
either of these genes is mutated or altered, DNA damage may not be repaired properly,
thus increasing the likelihood that additional genetic alterations can subsequently occur,
leading to cancer (American Cancer Society, 2015a). Thus, women with identified
deleterious mutations on the BRCA1/2 genes have a significantly increased lifetime risk
of developing breast cancer (i.e., 40 - 85%), as well as other cancers, including ovarian
cancer, pancreatic cancer, and melanoma (Antoniou et al., 2003).
Genetic testing and counseling are becoming increasingly more available;
however, not all individuals at risk get tested, and positive results lead to difficult
discussions and decisions. For women who have undergone genetic testing and received
positive results in terms of a BRCA1/2 mutation, a multidisciplinary, individualized
medical evaluation and treatment approach has been demonstrated to be beneficial
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(Pruthi et al., 2010). This approach offers the ability to educate those at high risk of
developing cancer about prevention and risk-reducing options, as well as to provide the
chance to detect cancer early and to improve survival. This approach, however, is not
always available (Pruthi et al., 2010). This multidisciplinary approach typically involves
a healthcare team, which may include a primary-care physician, gynecologist, breast
surgeon, plastic surgeon, gynecological oncologist, and others. These healthcare
professionals may collaboratively help their shared patient decide the path to take in
terms of prevention, both when the individual has not had cancer and when the individual
has had cancer.
The three most common preventative pathways that individuals with BRCA1/2
mutations choose from are surveillance, chemoprevention, and preventative surgery
(Pruthi et al., 2010). The surveillance pathway often involves regular mammograms,
breast magnetic resonance images (MRIs), and manual breast exams by a healthcare
professional (Nelsen, Huffman, Fu, & Harris, 2005; Saslow et al., 2007), whereas the the
chemoprevention pathway involves taking a medication designed to decrease the risk of
cancer development, and the preventative surgery pathway involves a prophylactic
bilateral mastectomy (PBM)(Friedman, Sutphen, & Steligo, 2012). The decision to
pursue one of these pathways over another is difficult and personal; ideally, this decision
is made with the support of a multidisciplinary healthcare team. Despite the support that
women with BRCA1/2 mutations have through various members of the healthcare
system, these women are placed in the position of choosing between the “lesser of two
evils” in terms of cancer prevention efforts.

BRCA1/2, SELF-CONCEPT, AND BODY IMAGE

3

While research has begun to address the psychological impact and distress that
those with BRCA1/2 mutations experience, possibly as a result of the life-changing
decisions that accompany this diagnosis, much of the research focuses on the effects of
genetic testing and is short term in scope. Among the studies that have examined distress
in women who received positive results in terms of BRCA1/2 mutations, some women
have shown increased distress post test (e.g., Dorval et al., 2008; Graves et al., 2012;
Reichelt, Moller, Heimdal, & Dahl, 2008), while others have shown no change or less
distress (e.g., Smith et al., 2008; Timman, Stijnen, & Tibben, 2004). This inconsistency
suggests that other variables, such as preventative treatment choices, are mediating,
moderating, or otherwise affecting the relationship between carriers of BRCA1/2 and
distress. This absence of elevated distress also may reflect a habituation to the persistent
distress associated with being in a family with hereditary breast and ovarian cancer
(HBOC) syndrome (Lerman, Schwartz, Narod, & Lynch, 1997).
Increased levels of distress among carriers of BRCA1/2 mutations are associated
with a greater number of unmet needs, including various emotional and functional needs,
such as dealing with uncertainty about the future, fears about cancer, and identifying
resources to make the most informed healthcare decisions (Farrelly et al., 2013). To meet
the overall needs of this population and to ensure that women with BRCA1/2 mutations
receive quality care, one must understand the process of adjustment to being at risk of
hereditary breast cancer (Den Heijer et al., 2011). Ben Zur (2002) suggested that
psychological resources, such as self-esteem, play a crucial role in the adjustment to
stressful life events. Self-esteem in particular is strongly associated with psychological
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functioning, as well as with higher levels of overall well-being in patients with cancer
(Schroevers, Ranchor, & Sanderman, 2003). Self-esteem is considered one dimension of
self-concept, with self-concept defined as the sense of being separate and distinct from
others, as well as the awareness of the constancy of the self (Curbow, Somerfield, Legro,
& Sonnega, 1990). Self-concept consists of five significant elements, all of which are
affected during the diagnosis and treatment of cancer: alteration in bodily experience,
discrepancy between actual and ideal self, disruption of personal relationships, selfdeprecating meaning of cancer, and depression (Katz, Rodin, & Devins, 1995).
Both gynecological cancers and breast cancers have a unique and significant
effect on the self-concept and body image of women (Kullmer et al., 1999). A significant
impact on self-concept of patients with cancer has been demonstrated and is even more
pronounced in women with recurrent disease episodes (Kullmer et al., 1999).
Additionally, Esplen et al. (2009) has been suggested that one negative impact of
receiving a BRCA1/2 diagnosis alone can alter one’s body image and self-concept. In
women with BRCA1/2 mutations, disturbances in body image have been found,
specifically in terms of altered breasts and breast sensation, mistrust of body, loss of
sensation or function, feeling older, loss of reproductive functioning, weight gain, and
altered body shape (Hallowell, Mackay, Richards, Gore, & Jacobs, 2004; McGaughey,
2006). Any new information about oneself, such as a breast cancer or BRCA1/2
diagnosis, can threaten an existing self-concept, with the treatment/prevention options of
these diagnoses also affecting body image (McConkie-Rosell & DeVillis, 2000). Body
image is often impaired as a result of cancer treatments, which can include
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chemotherapy, radiation, and surgery components (Kullmer et al., 1999). These
impairments in body image and self-concept persist for long periods of time, as
demonstrated in studies of patients with breast cancer (Lasry & Margolese, 1992; Taylor,
Lichtman et al., 1995).
Owing to the presence of multiple similarities in the research between carriers of
the BRCA1/2 mutation and women with breast cancer, these disturbances in self-concept
and body image likely are also shared between these populations. These alterations in
self-concept and body image are likely more prevalent in women with BRCA1/2
mutations who have undergone prophylactic surgery or surgery as part of breast cancer
treatment, as the literature generally does not distinguish between these two groups of
women. These alterations in self-concept and body image may be particularly evident in
women with BRCA1/2 mutations who have undergone a PBM, as these women have
experienced significantly more changes and alterations in their bodies compared to
women with BRCA1/2 mutations who have chosen surveillance or chemoprevention
options. Thus, a link between body image and self-concept may be more pronounced in
women with BRCA1/2 mutations, especially those who have undergone a prophylactic
surgery (i.e., a PBM).
Purpose of the Study
The purpose of this study is to explore self-reports of body image and selfconcept in women with deleterious BRCA1/2 mutations, with a specific focus on women
with deleterious BRCA1/2 mutations who have either undergone a PBM to decrease the
chance of developing breast cancer or elected to engage in surveillance methods to
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monitor cancer risk. Data were obtained through electronic surveys presented to women
through various online methods. At present, little is known about the characteristics and
needs of this population. Exploring the unique struggles that women with BRCA1/2
mutations face will help The more that is understood about the obstacles this population
faces, the better the chances that medical and mental-health professionals will be able to
identify problems in clients when they arise in order to ensure that the needs of this
population are met to increase the overall understanding and unique needs of this
population. Thus, this study adds to the growing literature base about women with
BRCA1/2 mutations in terms of their obstacles and needs.
Literature Review
Breast Cancer
Among women in the United States, breast cancer is the second most commonly
diagnosed cancer and is the second-leading cause of death (American Cancer Society,
2015b). Worldwide, more than 1,000,000 new cases of breast cancer are diagnosed every
year (Friedman et al., 2012). In the United States, it is estimated that 234,190 new cases
of breast cancer will be diagnosed in 2015, with an estimated 40,730 deaths from breast
cancer occurring each year (American Cancer Society, 2015b). Breast cancer deaths have
declined since 1990 as the result of an increase in public awareness, better methods of
early detection and prevention, and treatment advances (Friedman et al., 2012). However,
the diagnosis and death rates remain high, reinforcing the need for additional research
into treatment and prevention efforts.
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Types of breast cancer. Although several types of breast cancers exist, studies
rarely report the types of breast cancer developed by participants or the specifics of these
cancers. In general, breast cancer typically begins in the glands that produce milk
(lobules) or in the tubes that carry milk to the nipple (ducts; Friedman et al., 2012). The
tumors that grow within the breast are either in situ, which are early-stage breast cancers
that remain within the lobules or ducts, or invasive, which have the potential to
metastasize through the blood to other parts of the body (Friedman et al., 2012). This
potential is true for the five main types of breast cancers: ductal carcinoma in situ
(DCIS), lobular carcinoma in situ (LCIS), invasive ductal carcinoma (IDC), invasive
lobular carcinoma (ILC), and inflammatory breast cancer (IBC).
DCIS is a breast cancer that develops in the milk ducts within the breast and is
found to be as common as one in five new breast cancer cases (Friedman et al., 2012).
This type of breast cancer is considered the earliest stage of breast cancer; however, if
undetected and untreated, it has the potential to become invasive and metastasize
(Friedman et al., 2012). Unfortunately, this cancer is often too small to be felt and is
typically found only during a routine mammogram or MRI). Similar to DCIS, LCIS also
typically cannot be felt, as it is often found during biopsies when examining suspicious
lumps, microcalcifications (i.e., residue from rapidly dividing cells that may signal early
cancer), or another abnormality found on a regular screening (Friedman et al., 2012).
LCIS is most common in premenopausal women and is not considered a true breast
cancer, as it involves the presence of abnormal cells that signal a higher-than-average risk
of developing invasive breast cancer (Friedman et al., 2012).
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While DCIS and LCIS represent a lack of spread of cancer beyond the ducts or
lobules, IDC is a true breast cancer that has spread beyond the ducts to surrounding breast
tissue (Friedman et al., 2012). IDC is the most common breast cancer, representing 80%
of all cases, and is more common after age 55 years (Friedman et al., 2012). Similar to
IDC, ILC is a true breast cancer that has spread beyond the lobules to surrounding breast
tissue (Friedman et al., 2012). IDC represents 10% of all breast cancers and is more
commonly diagnosed after age 60 years (Friedman et al., 2012). Finally, IBC is a true
breast cancer that presents much differently from other breast cancers. IBC often begins
with reddening or swelling of the breast rather than with a lump, and its symptoms can
worsen significantly within a single day (Friedman et al., 2012). This type of cancer
represents only 1 to 3% of all breast cancers and is most common in women in their
fifties (Friedman et al., 2012).
Within these five main types of breast cancer, differences exist in terms of tumor
characteristics and staging. In terms of tumor characteristics, the involvement and role
that hormones play in the cancer are imperative in determining the best treatment for the
individual. Cancers with hormone receptors are referred to as estrogen receptor-positive
(ER+) and progesterone receptor-positive (PR+) and respond well to antihormone
treatments that can either reduce the amount of estrogen or progesterone in the body or
block the tumor’s ability to use those hormones to grow (Friedman et al., 2012).
Additionally, approximately one in three cancers overexpresses the HER2/neu protein,
which is a protein that promotes the growth of cancer cells (Friedman et al., 2012).
Cancers that are characterized by an overexpression of the HER2/neu protein respond
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well to treatments that target these specific receptors. Some cancers, however, do not
respond to hormone therapies (i.e.., are not ER+ or PR+) and are also not sensitive to
HER2/neu treatments. These cancers are referred to as triple-negative breast cancers and
represent 15% of all breast cancer diagnoses (Friedman et al., 2012).
Cancer staging is the process of determining the extent to which a cancer has
developed based on the size or extent of the primary tumor and whether or not cancer has
spread through the body (Friedman et al., 2012; National Cancer Institute, 2015). Staging
helps physicians plan appropriate treatments, determine patient prognosis, identify
possible clinical-trial options, and exchange information about patients with other
healthcare providers (National Cancer Institute, 2015). Stages are represented on a scale
from 0 to 4, with higher numbers indicating more extensive disease (National Cancer
Institute, 2015). Stage 0 is considered a preinvasive cancer that has not spread and
includes a diagnosis of DCIS (Friedman et al., 2012; National Cancer Institute, 2015).
Stages 1 through 3 depend on tumor size and lymph node involvement, the greater the
severity, the higher the stage (Friedman et al., 2012; National Cancer Institute, 2015).
Finally, Stage 4 represents metastasized cancer, or cancer that has spread to distant
tissues or organs (Friedman et al., 2012; National Cancer Institute, 2015).
Hereditary cancer. Genes contain instructions for critical body functions and
hold all hereditary information and material passed from parent to child (Friedman et al.,
2012). Cells often develop mutations when they divide, with some mutations occurring as
a result of environmental and lifestyle influences, such as smoking, chemical exposure, or
alcohol consumption (Friedman et al., 2012). However, the body frequently repairs
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genetic damage before the mutation is copied to new cells (Friedman et al., 2012). At
times, genetic damage cannot be repaired, sometimes as a result of a genetic mutation in
a tumor suppressor gene. This unrepairable damage creates a vicious cycle of replication,
resulting in passing unrepaired mutations onto the next generation of cells (Friedman et
al., 2012). Similarly, if an error occurs in the egg or sperm, it may pass from parent to
child in successive generations, which is the case with hereditary cancer (Friedman et al.,
2012).
In recent years, scientists have discovered several genetic mutations that can
contribute to an individual’s risk of developing certain kinds of cancers, including breast
cancer. Approximately 10 to 15% of all cases of breast cancer are the result of genetic
predisposition, meaning that they are hereditary, and not sporadic breast cancers (Lux et
al., 2006; Pruthi et al., 2010). Hereditary cancers differ from sporadic cancers in a variety
of ways. Hereditary breast cancers often occur at an earlier age than sporadic forms of
breast cancer. As a result, those at risk for hereditary breast cancer are recommended to
follow different cancer screening plans different from the general population (e.g.,
beginning routine screening at earlier ages) and have different risk reduction strategies
available to them (National Cancer Institute, 2015). Several genetic mutations have been
linked to an increased risk of developing a hereditary breast cancer.
Genetic Mutations
Two categories of genes are associated with increased risk of breast cancer
(Friedman et al., 2012). The first category of mutations, including BRCA1/2, TP53,
PTEN, STK11, and others, is considered rare and is associated with a significant increase
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in risk (Friedman et al., 2012). For example, BRCA1/2 mutations are most prevalent in
the Ashkenazi Jewish community, with one in 40 of these individuals testing positive,
compared to one in 350 to one in 500 in the general population (Friedman et al., 2012). A
subset of this grouping of mutations includes ATM, CHEK2, PALB2, and other genes,
which are linked to a higher risk of breast cancer than those in the general population, but
lower risk than that associated with BRCA mutations (Friedman et al., 2012). The second
group includes various single nucleotide polymorphisms, which are mutations that only
slightly increase breast cancer risk (Friedman et al., 2012). Despite this multitude of
genetic mutations that can contribute to the potential development of breast cancer, most
incidents of hereditary breast cancer are caused by two mutated genes: the BReast
CAncer1 and BReast CAncer2 (BRCA1/2) genes (Friedman et al., 2012; Lux et al., 2006;
Pruthi et al., 2010).
BRCA1/2 mutations. The BRCA1/2 genes are human genes that produce tumor
suppressor proteins that help repair damaged DNA (American Cancer Society, 2015a).
When either of these genes is mutated or altered, DNA damage may not be repaired
properly, thereby increasing the likelihood that additional genetic alterations can occur
and subsequently lead to cancer (American Cancer Society, 2015a). Having two copies of
each damage-repairing gene, or each BRCA1/2 gene, acts as a backup repair system: If
one gene is mutated and cannot repair damage, the other one can (Friedman et al., 2012).
Thus, being born with a single BRCA1/2 mutation does not guarantee the development of
breast cancer, as the healthy BRCA gene can effectively and efficiently repair DNA
damage as it occurs (Friedman et al., 2012). However, when both copies of a BRCA1/2
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gene are mutated or not working, this damage control process is deactivated, meaning
that the gene does not make the proteins that are required to repair DNA damage within
the cells (Friedman et al., 2012). Over time, cells continue to divide, replicating
additional damage by producing unregulated copies of the gene. This process of
replicating damaged DNA leads to the development of a tumor and, in this case, breast
cancer (Friedman et al., 2012).
As those with BRCA1/2 mutations already have one mutated copy of the gene,
women with identified deleterious mutations on the BRCA1/2 genes have a significantly
increased lifetime risk of developing breast cancer (i.e., between 40 and 85%), as well as
other cancers, including ovarian cancer, pancreatic cancer, and melanoma (Antoniou et
al., 2003; Friedman et al., 2012). While an average breast tumor develops over 6 to 8
years before it is large enough to be found by regular screenings, the development of
breast tumors often occurs sooner for women with BRCA1/2 mutations because the first
step in cancer development (i.e., disabling one copy of the protective or tumor suppressor
gene) has already occurred (Friedman et al., 2012). Additionally, women with BRCA1
mutations are more likely to develop triple-negative breast cancer, and women with
BRCA 2 mutations are more likely to develop ER+ and PR+ cancers; these greater
probabilities are likely caused by the increased vulnerability to these particular breast
cancers as a result of the lack of strength and longevity of the BRCA1/2 genes (Friedman
et al., 2012).
Deleterious BRCA1/2 mutations. HBOC families are those who have strong and
identifiable patterns of early-onset breast and/or ovarian cancer, as well as of other
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related cancers (Friedman et al., 2012). Since 1994 to 1995, when the two most
significant breast cancer susceptibility genes (i.e., BRCA1/2) were identified, those in
HBOC families have been able to be tested for BRCA1/2 mutations (Miki et al., 1994;
Wooster et al., 1995). Among HBOC families, only approximately 15% to 20% actually
possess deleterious BRCA1/2 mutations (Lux et al., 2006). Deleterious BRCA1/2
mutations are those that are known, through identification and research, to significantly
increase an individual’s chance of developing cancer (Friedman et al., 2012). In the
United States, the general presence of deleterious BRCA1/2 and related mutations is
about 0.2% (Ponder et al., 2000).
Despite the rarity of these mutations, they are believed to account for
approximately 5 to 10% of all breast cancer cases (Den Heijer, Vos et al., 2012; Szabo &
King, 1995). For women who have already been diagnosed with breast cancer and are
BRCA1/2 positive, their risk of contracting a second primary breast cancer is
significantly elevated; this chance can be as high as 70% when breast conservation was
chosen as a treatment option (Evans, Skrzynia, Susswein, & Harlan, 2005). Interestingly,
members of the same HBOC family tend to develop different types of cancer at different
ages, with some never developing cancer in their lifetimes (Evans et al., 2005). The
clinical utility of this testing is evidenced by high rates of risk-reducing surgeries by
BRCA1/2 carriers over the long term (Beattie, Crawford, Lin, Vittinghoff, & Ziegler,
2009; Evans et al., 2009; Friebel et al., 2007; Metcalfe, Birenbaum-Carmelo et al., 2008;
Metcalfe, Lubinski et al., 2008; Schwartz et al., 20012), as well as the resulting decrease
in morbidity and mortality (Domchek et al., 2010). Thus, knowing one’s BRCA1/2 status
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allows those in HBOC families to actively participate in prevention, early detection, and
treatment (Bagtecky, Tondlova, Vesela, Brizekova, & Bololoucky, 1996; Miki et al.,
1994), which is the reasoning behind making BRCA1/2 testing an integral part of
treatment and screening for women from HBOC families (Friedman et al., 2012).
Preventative Options
Testing for BRCA1/2 mutations facilitates a decrease in morbidity and mortality
related to inherited breast and ovarian cancer when close and careful clinical management
is used (Borreani et al., 2014). In terms of clinical management, three main cancer risk
management strategies typically are used with women with BRCA1/2 mutations:
increased surveillance, chemoprevention (Friedman et al., 2012), and prophylactic
surgery (Friedman et al., 2012). While the combination of self-exams, mammography,
and MRI improves the odds of finding early tumors, it does not decrease the likelihood of
getting cancer in this population; however, chemoprevention and prophylactic surgery
decrease the likelihood of cancer occurrence in this population (Friedman et al., 2012).
Surveillance. Experts generally agree that intensive surveillance for carriers of
BRCA1/2 is critical and that most cancers among carriers of BRCA1/2 are interval
cancers, meaning these cancers tend to be detected during intervals between screening
examinations (Friedman et al., 2012), suggesting that these cancers are often caught in
early stages. However, surveillance methods do not prevent breast cancer and have not
been proved to reduce breast-cancer-related death in carriers of BRCA1/2, as their
efficacy with carriers of BRCA1/2 is not as well documented as with the general
population (Pruthi et al., 2010). The variety of surveillance methods for breast cancer in
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women with BRCA1/2 mutations currently include breast self-exams, clinical breast
exams, mammography, and breast MRIs (Friedman et al., 2012). While the guidelines
and recommendations for breast self-exams (i.e., monthly as early as 18 years of age) and
clinical breast exams (i.e., one to two times per year starting at 25 years of age) are
relatively close to the recommendations for women in the general population, the
guidelines and recommendations for mammograms and breast MRIs are much different
(Friedman et al., 2012).
Friedman et L. (2010) recommend that women with BRCA1/2 mutations get
mammograms annually starting at 25 years of age, or between 5 and 10 years before the
earliest age of breast cancer onset in the family (Friedman et al., 2012). Mammograms
use low-dose x-rays to produce images of the internal breast structure and tend to find
microcalcifications, tiny calcium deposits that may precede tumor growth, long before
they can be felt (Friedman et al., 2012). However, some drawbacks to mammography
include its tendency to miss some breast cancers, especially in younger women with
dense breast tissue, and its tendency to be less sensitive than other surveillance methods
(Friedman et al., 2012). Additionally, some controversy exists regarding the radiation
exposure of mammography. Some experts believe that the increased lifetime exposure to
radiation from beginning exposure before the age of 30 years could lead to slightly
increased breast cancer risk (Friedman et al., 2012; Ronckers, Doody, Lonstein, Stovall,
& Land, 2008). Owing to this concern, some physicians and healthcare professionals
treating those with BRCA1/2 mutations recommend mammography not begin until 30
years of age (Friedman et al., 2012); however, one study looking at the potential risk
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associated with mammography exposure in young carriers of BRCA1/2 mutations
determined that mammograms were estimated to save more lives than would be lost to
radiation-induced breast cancers (de Gonzalez, Berg, Visvanathan, & Robson, 2009).
Similarly, Friedman et al. (2012) recommend that women with BRCA1/2
mutations get breast MRIs annually starting at 25 years of age, or 5 to 10 years before the
earliest age of breast cancer onset in the family (Friedman et al., 2012). MRI uses
magnetic fields and radio waves to produce detailed images of the breast from several
angles and does not produce radiation (Friedman et al., 2012). MRI may be particularly
adept at finding cancers that mammograms miss, especially in premenopausal women, as
MRI is a sensitive screening tool that finds abnormalities at a higher rate than
mammography (Friedman et al., 2012), with this rate being approximately 80%
sensitivity of malignancy detection (Pruthi et al., 2010). While most studies find MRI to
be more sensitive compared to mammograms, when used together, these surveillance
methods are complementary, with each having its own strengths and each tending to find
some cancers better than the other (Friedman et al., 2012). For example, Lord et al.
(2007) suggested that adding MRI to mammography improves malignancy detection
sensitivity from 40 to 94% in young, high-risk women (Lord et al., 2007).
Chemoprevention. Some women with BRCA1/2 mutations choose
chemoprevention to reduce their risk of breast cancer occurrence. Chemoprevention
involves taking medications that have been proved to decrease cancer risk; while
chemoprevention does not guarantee that one will never develop cancer, different
chemopreventaitive medications have been shown to significantly reduce the risk of
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developing cancer (Friedman et al., 2012). Two of the most common and most researched
medications used for chemoprevention are tamoxifen and raloxifene, both of which are
selective estrogen receptor modulators (SERMs), drugs that block estrogen (Friedman et
al., 2012). Additionally, tamoxifen and raloxifene are both FDA-approved medications
that reduce the risk of developing breast cancer in high-risk women (Friedman et al.,
2012).
The pros and cons of chemoprevention differ depending on the particular drug
that is used. In terms of tamoxifen, some of the positive effects include reducing the risk
of ER+ breast cancer, decreasing the risk of invasive breast cancer, strengthening bones,
lowering LDL cholesterol levels, and continuing benefits even after the drug is no longer
taken (Friedman et al., 2012). Despite these various positive effects, tamoxifen possesses
the potential for a variety of negative effects, including an increase in risk for blood clots
and uterine cancer and the triggering of menopause-like symptoms (Friedman et al.,
2012). Raloxifene shares many of the positive effects of tamoxifen, including lowering
LDL cholesterol levels and strengthening bones, but it also is more effective against
noninvasive breast cancer and is characterized by a lower risk of uterine cancer than
tamoxifen (Friedman et al., 2012). Some of the negative effects associated with
raloxifene include an increased risk for blood clots and menopause-like symptoms
(although a lower risk than with tamoxifen) and declining benefits when it is no longer
taken (Friedman et al., 2012). In general, SERM medications are known to cause vaginal
bleeding or discharge, headaches, nausea, leg cramps, rashes, mood changes, and other
serious side effects, as previously noted (Friedman et al., 2012).
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Prophylactic bilateral mastectomy (PBM). Women with BRCA1/2 mutations
are given the option of pursuing a PBM) by their physicians as a preventative option
(Hoskins, Roy, & Greene, 2012). One of the decisions that women pursuing a PBM need
to consider, with the consultation and recommendation of their physicians, is whether to
undergo a total or nipple-sparing PBM. A total PBM involves the removal of 95 to 99%
of the breast tissue, including the nipple, with or without the removal of the pectoral
muscle (Metcalfe, Esplen, Goel, & Narod, 2004). Differently, a subcutaneous, or nipplesparing, PBM involves the removal of 90 to 95% of the breast tissue, while preserving
the nipple and skin that covers the breast (Friedman et al., 2012). Both of these options
can also involve breast reconstruction, which could be performed with a variety of
different methods that restore the general look and shape of breasts (Friedman et al.,
2012).
As DNA testing becomes more widely available and the cosmetic results of breast
reconstruction improve, PBM continues to emerge as an important option for women
with BRCA1/2 mutations to decrease their overall and lifetime risk of breast cancer (Den
Heijer, Seynaeve, Timman et al., 2012). Despite the obstacles and challenges associated
with PBM, more women with BRCA1/2 mutations are pursuing PBM to decrease their
risk of breast cancer (Hartmann et al., 2001; Lynch et al., 2006). Approximately 57% of
women at high risk of breast cancer identified PBM as an option in one study (Stefanek,
1995), but generally fewer women, from 16 to 20%, identify PBM as a favorable option
(Eisinger et al., 1997; Grana et al., 1994). Additionally, rates of 9 to 17% of women who
express an interest in PBM choose to pursue this preventative surgery (Grana et al., 1994;
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Lerman et al., 1996; Stefanek, 1995). Differences in the interest and uptake of PBM have
been identified in different countries. For example, in one study, 35% of women with
BRCA1/2 mutations in the United States reported considering PBM after receiving
genetic testing results (Lynch et al., 1997), compared to 8% of this population in Austria
(Wagner et al., 2000) and 65% of this population in Canada (Metcalfe et al., 2000).
Overall, undergoing a PBM has been shown to reduce breast cancer risk in
women with BRCA1/2 mutations by 90 to 95%, meaning that women with BRCA1/2
mutations can achieve a level of breast cancer risk that is the same or less than that of the
general population (Domchek et al., 2010; Hollingsworth et al., 2004; Rebbeck et al.,
2004). One study found that PBM, with or without reconstruction, reduced breast cancer
risk in women with BRCA12 mutations by 90 to 100%, although the impact of PBM has
not been identified or described in terms of survival rates compared to intensive
surveillance methods (Hartmann et al., 2001; Heemskerk-Gerritsen et al., 2013; MeijersHeijboer et al., 2001; Rebbeck et al., 2004). PBM is often considered personally and
emotionally charged and involves recurring decision making throughout the lifetime
(Hoskins et al., 2012). The psychological and emotional effects of undergoing a bilateral
mastectomy (BM) in survivors of breast cancer are well documented; however, the
psychological and emotional effects of undergoing a PBM are not well known (Metcalfe,
Esplen, Goel, & Narod, 2004). One study suggests that those who pursue BM after a
cancer diagnosis compared to those who pursue PBM without a cancer diagnosis are
characterized by different profiles regarding demographic and clinical characteristics,
preventative choice, risk perception, cancer worry, quality of life, and satisfaction scores
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(Borreani et al., 2014). While similarities may exist between these two groups of women,
the research on women who underwent BM after a breast cancer diagnosis has typically
focused on women from single institutions (Metcalfe et al., 2004), have not been
population based (Hatcher, Fallowfield, & A’Hern, 2001), or have been based on small
samples (Stefanek, Helzlsouer, Wilcox, & Houn, 1995).
Several studies have examined the psychological aspects associated with the
choice of preventative strategy (Bisch et al., 2002; Bresser, Seynaeve et al., 2007; Claes
et al., 2005; Lobb & Meiser, 2004; Ray, Loescher, & Brewer, 2005), as well as the
impact of this choice (Bresser, Van Gool et al., 2007; Hatcher et al., 2001; Madalinska et
al., 2007; Tercyak et al., 2007; ; Tiller et al., 2002). However, some of these studies
compared women with different risk profiles without considering genetic-testing results
(Bish et al., 2002; Claes et al., 2005; Schwartz et al., 2012), while others examined both
affected and unaffected women together (Bresser, Seynaeve et al., 2007; Lobb & Meiser,
2004; Ray et al., 2005). Additionally, some studies kept affected and unaffected women
separate, but focused on describing the psychological impact (i.e., distress) of genetic
testing without considering chosen preventative strategies (Eijzenga, Hahn, Aaronson,
Kluijt, & Bleiker, 2014). Lower levels of distress after surgery completion are associated
with higher levels of satisfaction; additional variables associated with higher levels of
satisfaction include satisfaction with body appearance, lower levels of life stress, fewer
problems with implants, and no reconstruction after PBM (Frost et al., 2000). Another
study found that breast reconstruction was a contributing factor to decreased
psychological distress after surgery, as those who underwent reconstruction reported
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feelings of femininity, wholeness, and normalcy (Stevens et al., 1984; Wellisch, Schain,
Noone, & Little, 1985). Overall, most women appear to be satisfied post-surgery with
their choice to undergo PBM, with studies showing between 70 and 97% of women
reporting satisfaction and decreased cancer worry (Frost et al., 2000; Metcalfe et al.,
2004).
Risk Perception and Decision Making
While more women who have experienced breast cancer get a BM, a substantial
proportion of women who have not had cancer pursue a PBM (Borreani et al., 2014). One
study examined 139 women with BRCA1/2 mutations in the Netherlands (MeijersHeijboer et al., 2001). After receiving positive genetic-testing results, 76 of these women
chose to undergo a PBM, with the remaining 63 choosing to be followed with a
surveillance protocol. This cohort was followed for 2.9 years; during this time, none of
the individuals who chose the PBM pathway were diagnosed with breast cancer, while
eight of the individuals who chose to be monitored via the surveillance pathway were
diagnosed with breast cancer. A significant body of research has been dedicated to
determine the factors and circumstances that contribute to the decision by women with
BRCA1/2 mutations to pursue a PBM instead of chemopreventaitive or surveillance
pathways.
Risk is a major decision-making factor regarding genetic testing, screening and
risk-reducing options, and other BRCA1/2-related issues (Hoskins et al., 2012).
Perceived risk also influences the psychological and emotional effects of these decisions
(Hoskins et al., 2012); this highlights the significance of accurate risk perception for
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women with BRCA1/2 mutations making these potentially life-altering decisions
regarding breast health (Hopwood, Howell, Lalloo, & Evans, 2003), as well as of the
detriment inaccurate risk perception can have on individuals who are attempting to make
risk management decisions (Kelly et al., 2005). The beliefs that people hold about their
vulnerability to different diseases can serve as powerful motivational factors to engage in
health behaviors (Hamilton & Lobel, 2012). For example, women who perceive
themselves to be at higher risk for breast cancer are more likely to follow through with
mammograms and to pursue genetic testing for BRCA1/2 mutations (Hamilton Lobel, &
Moyer, 2009; Katapodi, Lee, Facione, & Dodd, 2004; McCaul, Reid, Rathge, &
Martinson, 1996).
While this relationship between risk perception and health behaviors appears
simple, it is multifaceted and complex (Hoskins et al., 2012). The thought processes of
women with BRCA1/2 mutations are linked to information they receive from various
sources (e.g., counselors, health professionals, testing reports, family, friends), their
assumptions regarding the experience of having cancer, their family formation desires,
and their view of the best interest of themselves and their loved ones (Hoskins et al.,
2012). Thus, many nononcologic aspects of perceived risk exist, including thoughts of
dying and leaving their children motherless and inflicting a traumatic experience on loved
ones, are integral to the self-understanding of women with BRCA1/2 mutations as
mutation carriers, of their risk, and of their decisions about managing it (Hoskins et al.,
2012). Some research has suggested that the higher the risk perception of women with
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BRCA1/2 mutations, the more likely they are to choose PBM over other risk
management strategies, such as surveillance or chemoprevention.
Much of the research on decision making for women with BRCA1/2 mutations
focuses on the decision to move forward with a PBM. Many factors are involved in
choosing PMB for carriers of BRCA1/2, including fear, physician advice, concern about
breast cancer (Frost et al., 2000), the desire to be proactive, intrusive cancer worry,
vulnerability resulting from life stage (Hopwood et al., 2000), personal tolerance for
inaction, assumptions about the experience of having cancer if they were diagnosed,
family formation and planning issues, the implications of their choices for close others
(Hoskins et al., 2012), depression levels, family history, having young children (Bish et
al., 2002; Lobb & Meiser, 2004; Claes et al., 2005; Ray et al., 2005; Bresser, Seynaeve et
al., 2007; Landsbergen, Brunner, Manders, Hoogerbrugge, & Pins, 2010), and
information-processing abilities (Landsbergen et al., 2010; Watts et al., 2012).
Additionally, those with higher levels of anxiety are more likely to undergo a PBM
and/or to choose chemoprevention; however, these same individuals are also more likely
to be dissatisfied with their decision (Ertmanski et al., 2009).
Women tend to choose PBM more often when they are younger, have children,
have had breast cancer, have a strong family history of breast cancer, and overestimate
their cancer risk or are characterized by high levels of cancer-related anxiety (Meiser et
al., 2000; Metcalfe, Lubinski et al., 2008; Singh et al., 2013). For women who choose
PBM, significant reductions in cancer risk perception often occur; this reduction is true
both of women who pursue this surgery preventatively and of women who have
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previously had cancer (Borreani et al., 2014). This reduction suggests that, for women
with BRCA1/2 mutations, the effectiveness of the surgery was understood in terms of its
potential to reduce cancer risk (Domchek et al., 2006; Lostumbo, Carbine, & Wallace,
2012). Interestingly, the risk perception after surgery remained greater than the actual
residual risk, highlighting a continued pattern of risk overestimation in this group of
women (Borreani et al., 2014). While decision making regarding the management of
health concerns and cancer surveillance can reduce distress in the population with
BRCA1/2 mutations (Esplen et al., 2004; Hamilton, 2009; Lerman et al., 1996; Lobel,
Hamilton, & Moyer, 2009; Meiser, 2005; Smith et al., 2008), it can also serve to increase
stress in this population (Lerman et al., 1997; Watson et al., 2004).
Testing Distress
BRCA1/2 testing poses important clinical implications for those who are carriers
for these mutations (Smith et al., 2008). This testing allows carriers to make more
informed healthcare choices, often leading to further screening and treatment decisions,
including chemoprevention and prophylactic or more aggressive surgical procedures
(Peshkin et al., 2002; Schwartz et al., 2003; Schwartz et al., 2004; Van Oostrom et al.,
2003). Understanding the distress that women experience during the genetic testing
process helps to clarify some of the psychological needs of this population, as well as to
outline the value of surgical strategies for women at increased risk for cancer (Smith et
al., 2008). Additionally, understanding distress in this population can help to reduce the
interference that distress plays in the information transfer that occurs during genetic
counseling, the decision-making process, and the follow-through with psychological
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interventions (Cull et al., 1999; Hopwood et al., 1998). Unfortunately, while a wealth of
information is available on this particular topic, the current research base presents
conflicting information about the distress experienced by this segment of the population.
Increased distress. Some research suggests that those who undergo genetic
testing experience increased levels of distress. A review of the literature found that
women who received a positive genetic-testing result reported experiencing fear for the
future, helplessness, depression and anxiety, worry about family members, and the
unpredictability of their situation, and they described themselves as “ticking time
bombs.” Many of these experiences are common in those who are diagnosed with breast
cancer (DiMillo et al., 2013). Receiving a positive BRCA1/2 mutation result has been
found to be linked with increased levels of anger and distress (Croyle, Smith, Botkin,
Baty, & Nash, 1997; Dorval et al., 2000), decreased quality of life, an altered selfconcept, vulnerability, stigma (Esplen et al., 2009), increases in cancer perception and
worry about cancer (DiProspero et al., 2001), and increased levels of anxiety and
depression (Bober, Hoke, Duda, Regan, & Tung, 2004; Lerman, Seay, Balshem, &
Audrain, 1995; Lindberg & Wellisch, 2004; Van Oostrom et al., 2003; Wellisch &
Lindberg, 2001). Interestingly, Cukier et al. (2013) suggested that the high level of
cancer-related distress experienced by this population is consistent with symptoms
observed in posttraumatic stress disorder, a condition that typically occurs after a person
experiences trauma that poses a threat to life of the individual or another person
(Horowitz, Wilner, Kaltreider, & Alvarez, 1980). Maheu et al. (2014) added that higher
anxiety levels have been found to occur and sometimes persist after genetic testing,
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especially in a subgroup of carriers. This notion is supported by the research (JulianReynier et al., 2011; Segal et al., 2004; Van Oostrom et al., 2003). Other studies add that
carrier anxiety can linger for years (Meiser & Halliday, 2002; Schwartz et al., 2002),
lasting anywhere between 6 months and 5 years (Beran et al., 2008; Graves et al., 2012;
Julian-Reynier et al., 2011; Van Oostrom et al., 2003).
Samson et al. (2014) found that women reacted to their positive genetictesting
result as if they were diagnosed with breast cancer, even though they displayed no
clinical signs or symptoms associated with breast cancer. Similarly, several other studies
have shown that distress levels among carriers of BRCA1/2 mutations is higher than
among the general population and are similar to distress levels found among those with
breast cancer within a year of diagnosis (Braithwaite, Emery, Walter, Prevost, & Sutton,
2004; Croyle et al., 1997; Lindberg & Wellisch, 2004; Meiser et al., 2002; Meiser, 2005;
Tiemsland, Soreide, & Malt, 1998). Shiloh, Drori, Orr-Urtreger, and Friedman (2009)
explained that support exists for the idea that being objectively at an increased risk for
cancer is cognitively represented by perceived risk and causal attributions and that these
representations, rather than the objective membership in an “at risk” group, such as
BRCA1/2 previvors, are associated with levels of health anxiety and worry interference.
Lerman et al. (1997) found that cancer-specific distress was significantly and positively
related to the use of the BRCA1 test whereas global distress was found to be unrelated to
test use. Similarly, Dorval et al. (2008) explained that irrespective of cancer diagnosis,
women at high risk are more inclined to report psychological distress than women in the
general population, even before receiving their positive genetic-testing result.
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In addition to exploring the type and level of distress experienced by carriers of
BRCA1/2, some research has examined factors associated with higher levels of distress
in this population. Some research has shown that women who feel stigmatized or
otherwise different from others because of their increased risk for cancer experienced
increased levels of distress (Lux et al., 2006). Women with BRCA1/2 mutations also
appear to experience higher levels of distress when they have children, have lost a
relative because of breast or ovarian cancer, doubt the validity of the resting results (Van
Oostrom et al., 2003), are in a committed relationship (Beran et al., 2008), have higher
levels of anxiety pre testing (Den Heijer et al., 2013; Reichelt et al., 2008), and have
higher concerns related to developing cancer (Bosch et al., 2012).
Mixed results. In general, among the studies on short-term psychological distress
in carriers of BRCA1/2 after disclosure of genetic-testing results, some have shown
increased distress (Croyle et al., 1997; Lodder et al., 2001; Smith, West, Croyle, &
Botkin, 1999; Tercyak et al., 2001; Watson et al., 2004), while others have shown no
change in distress levels (Meiser et al., 2002; Reichelt, Heimdal, Moller, & Dahl, 2004;
Schwartz et al., 2002). Mixed results are also found suggesting that carriers of BRCA1/2
may experience higher levels of distress in the months soon after testing (Watson et al.,
2004; Meiser et al., 2002; Smith et al., 2008), with some of these differences dissipating
within 1 year of receiving testing results (Arver, Haegermark, Platten, Lindblom, &
Brandberg, 2004; Smith et al., 2008). Beran et al. (2008) highlighted this trend of
decreased stress over time after genetic testing for women with BRCA1/2 mutations
which is likely a result of decisions made during this time. For women with BRCA1/2
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mutations, these months post testing often involve making decisions about prophylactic
options and communicating results to family and friends, not to mention the individual’s
own cognitive and emotional processing of the results (Beran et al., 2008).
In terms of long-term impact of genetic testing, some studies have found that
among those who have no personal cancer history, no psychological differences are
present for carriers or noncarriers 1 year (Arver, Haegermark, Platten, Lindblom, &
Brandberg, 2004; Borreani et al.,2014; Bosch et al., 2012; Smith et al., 2008), 3 years
(Foster et al., 2007), and 5 years post testing (Van Oostrom et al., 2003). Differently, two
studies from Australia and the United Kingdom reflected an increase in anxiety
symptoms in women with BRCA1/2 mutations 1 year post testing (Meiser et al., 2002;
Watson et al., 2004). However, another study found statistically significant, but not
clinically significant, levels of genetic-testing distress in women with BRCA1/2
mutations compared with noncarriers (Halbert et al., 2011). Two recent long-term studies
examining genetic-testing-specific concerns found that American women were not likely
to express such concerns more than 4 years post testing (Halbert et al., 2011; Hamilton,
Williams, Skirton, & Bowers, 2009), while a similar study of French women showed an
increase in cancer risk perception over a 5-year follow-up period (Julian-Reynier et al.,
2011).
One study suggests that some of these mixed results may be owing to some
studies not separating out those with BRCA1/2 mutations who have versus who have not
had cancer (Meiser, 2005). Lodder et al. (2006) concluded that among those with no
cancer history, carriers of BRCA1/2 are not psychologically affected by their carrier
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status; for women with BRCA1/2 mutations who have had cancer, however, some studies
show no change in psychological distress while others indicate that survivors experience
more distress throughout the testing process (Horowitz, Wilner, & Alvarez, 1979).
Another possible explanation for the mixed results regarding increases in distress for
women with BRCA1/2 mutations post testing is that the focus should be on changes in
distress for these individuals: of importance may be that women with BRCA1/2
mutations do not experience decreases in distress post testing, while those who receive
negative testing results do experience this decrease (Croyle et al., 1997; Lerman et al.,
1996; Lodder et al., 2001; Schwartz et al., 2002). An additional possibility regarding the
wealth of literature that highlights a general absence of psychological distress may reflect
emotional habituation or adaptation to the persistent stresses associated with being in a
HBOC family and with the repeated and reoccurring need to make significant decisions
regarding one’s healthcare and life planning (Baum, Cohen, & Hall, 1993).
Thus, the experience of distress in women with BRCA1/2 mutations remains
unclear because of the mixed results in the literature. Despite these mixed findings, many
researchers agree that a subset of the population with BRCA1/2 mutations is more likely
than the rest of this population to experience distress (Braithwaite, Emery, Walter,
Prevost, & Sutton, 2006; Schwartz et al., 2002). Broadstock, Michie, and Marteau (2000)
reviewed 27 analyses from short-term studies that showed that pretesting emotional state
was the strongest predictor of psychological distress post testing; however, no studies
have examined the determinants of pretest distress, and concerns have been raised
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concerning the methodology of several of these studies (Timman et al., 2004;
Vadaparampil, Ropka, & Stefanek, 2005).
Distress after testing. Being faced with a great deal of new, complex, and
distressing information can potentially increase the likelihood of adverse psychological
reactions following testing (Roussi et al., 2010). While adapting to cancer risk, female
carriers of BRCA1/2 have to make some important decisions regarding their management
of this risk; these women are faced with a range of choices, including more frequent
screening and preventative surgical options (Lapointe, Dorval, Nogues, Fabre, & JulianReynier., 2013). These women also have to face the 50/50 possibility of passing on this
mutation to offspring, as well as the feelings of fear and guilt that this fear entails
(Lapointe et al., 2013). Compared to women at high risk for breast and ovarian cancer
without BRCA1/2 mutations, carriers of BRCA1/2 mutations tend to experience more
distress in the first year after genetic testing; these distress levels may fluctuate just
before and after surveillance visits and MRI result appointments, but may decrease over
time after going through risk-reducing surgery and achieving satisfaction with the
decisions that the individual made regarding her BRCA1/2 healthcare decisions
(Harmsen, Hermens, Prins, Hoogerbrugge, & De Hulu, 2012).
One overlooked aspect of carriers of BRCA1/2 mutations is the burdens they face
on a regular basis; these burdens may serve to affect the intensity of distress experienced
by this population (Lynch et al., 2006). Some of the burdens faced by this population
include (a) the guilt of passing the mutation to the next generation, (b) worry about
successive generations getting cancer, (c) worry about themselves getting cancer, (d) and
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concern about health insurance discrimination (Lynch et al., 2006). Additionally, carriers
of BRCA1/2 mutations who have experienced cancer appear to experience three
additional burdens that contribute to distress, including (a) feeling frustrated at having no
cancer prevention guidelines, (b) thinking about how their test result has affected their
work and family life, and (c) having problems finding enjoyment in life (Lynch et al.,
2006). These burdens are not just confined to the initiation and process of genetic testing
but may affect carriers of BRCA1/2 mutations throughout their lifespans, especially
during times of decision making regarding their BRCA1/2 diagnosis and risk for HBOC
(Lynch et al., 2006).
Factors influencing distress. The psychological adjustment of women who are at
high risk involves both personal and social resources, with one study suggesting that
personal resources are a way by which social resources may affect psychological distress
(Den Heijer, Vos et al., 2012). Some of the factors, or resources, that have been found to
be associated with higher levels of distress in women with BRCA1/2 mutations include
experiencing stigma (Den Heijer et al., 2011; Den Heijer, Vos et al., 2012); having low
income; being previously diagnosed with cancer (Cukier et al., 2013); experiencing poor
communication about hereditary cancer, thereby contributing to increased anxiety and
isolation (Den Heijer, Seynaeve, Vanheusden et al., 2012); and having a family history of
breast cancer and/or a mother who died from breast cancer (Erblich, Bovbjerg, &
Valdimarsdottir, 2000; Zakowski et al., 1997). Additionally, having young children and
the profoundness of one’s experience with cancer in relatives have been found to
contribute to neither higher nor lower levels of distress (Lodder et al., 2001).
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In terms of factors found to be associated with lower levels of distress in women
with BRCA1/2 mutations, self-esteem is an important personal resource that may serve to
buffer the effects of cancer-related stressors (Carpenter, 1997; Den Heijer et al., 2011;
Schroevers et al., 2003) and of distress in general (Den Heijer, Vos et al., 2012). Den
Heijer et al. (2011) found that self-esteem was negatively associated with general distress
but was not found to be associated with breast-cancer-specific distress. Stigma, however,
was found to be strongly associated with breast-cancer-specific distress, but the negative
effect of stigmatization was most pronounced for women with low self-esteem (Den
Heijer et al., 2011). Self-esteem and a sense of mastery reflect a sense of resilience and
may serve to buffer the individual from stressful effects and emotions related to being at
risk for HBOC (Den Heijer et al., 2011).
Social support during the genetic-testing process has also been found to be
associated with lower experiences of distress in this population (Den Heijer, Seynaeve,
Vanheusden et al., 2012; Koehly et al., 2008; Manne et al., 2004; Van Oostrom et al.,
2007), with the availability of social support being more strongly associated with health
outcomes than the actual use of social support (Carlsson, Bjorvatn, Engebresten,
Berglund, & Natvig, 2004). While some studies specifically highlight the significance of
partner support (Den Heijer, Seynaeve, Vanheusden et al., 2012), social support is
important in many forms, including the nuclear family, extended family, and friends
(Lapointe et al., 2013).
Social support is especially complex considering that hereditary cancer and
BRCA1/2 diagnoses have a profound impact on individual family members, as well as
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their communication and other interactions (DeMarco & McKinnon, 2007; Kenen,
Arden-Hones, & Eeles, 2004; Lodder et al., 2001). Therefore, family system
characteristics may influence the way that women learn to cope with a hereditary cancer
or BRCA1/2 diagnosis, experiences that affect the family system(Den Heijer, Seynaeve,
Vanheusden et al., 2012). Family patterns of openness and talking about
feelings/thoughts may facilitate insight (Kennedy-Moore & Watson, 2001), and
attempting to verbalize feelings about a BRCA1/2 diagnosis can help people to better
understand their own thoughts and feelings (Den Heijer, Seynaeve, Vanheusden et al.,
2012). Talking with others about HBOC and BRCA1/2 diagnoses can also lead to new
perceptions and a broader perspective on cancer-related worry (Den Heijer, Seynaeve,
Vanheusden et al., 2012), as well as contribute to a greater sense of psychological
adjustment. However, this openness may prove difficult for family members who are
indirectly affected by these diagnoses.
Adjusting to genetic-risk information may involve considerable challenges and
pose medical, emotional, and family relationship implications (Dorval et al., 2000;
Horsman et al., 2007). One of these challenges may be the process of deciding how to
convey the complex, and often emotionally charged, cancer risk information with
relatives at risk, intimate partners, and friends (Foster, Eeles, Arden-Jones, Moynihan, &
Watson, 2004). Communication with relatives about familial cancer risk serves several
purposes (D’Agincourt-Canning, 2001; Dancyger et al., 2011; Julian-Reynier et al.,
2000), including information passing (e.g., telling others of the cancer risk and genetic
mutation), fulfillment of personal needs (e.g., obtaining emotional support, getting
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medical advice; Bosch et al., 2012), and sharing, which is key to the maintenance of close
relationships and contributes to the exchange and procurement of social support (Rime,
2007). Thus, open communication within the family is also a factor associated with lower
levels of distress in women with BRCA1/2 mutations (Den Heijer, Seynaeve,
Vanheusden et al., 2012).
Social support is associated with better psychological adjustment over time, with
one study showing that this adjustment persists up to 2 years after disclosure of genetictesting results in women with BRCA1/2 mutations (Lapointe et al., 2013). Den Heijer,
Seynaeve, Vanheusden et al. (2012) found that social support and family communication
about hereditary cancer are of paramount importance in terms of long-term psychological
adjustment for women with BRCA1/2 mutations. Another study that examined
psychological distress in at-risk women 5 years post genetic testing showed that an open
family communication style was associated with less psychological distress long term
(Van Oostrom et al., 2003). It was found that open communication within the family
decreased isolation and stigmatization, which was also found to be true of those women
who talked openly about hereditary cancer with their intimate partners (Den Heijer, Vos
et al., 2012). Overall, the decrease in stigmatization is associated with less psychological
distress (Den Heijer, Vos et al., 2012), and open communication about hereditary cancer
in general may be one way that social support serves to buffer psychological distress in
women with BRCA1/2 mutations (Den Heijer, Seynaeve, Vanheusden et al., 2012).
Unmet needs. Unmet needs are those issues for which people perceive a need for
help (Farrelly et al., 2013). Higher levels of unmet needs have been found to be
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associated with higher levels of experienced distress, especially when combined with not
having someone to confide in (Farrelly et al., 2013). For patients with cancer, some
domains of unmet needs include assistance with daily-living activities, physical activities,
psychological well-being, and obtaining treatment or prevention information (Harrison,
Young, Price, Butow, & Soloman, 2009; Thewes, Meiser, Tucker, & Tucker, 2003).
While little is known about unmet needs for women with BRCA1/2 mutations, one study
has examined unmet needs in this population (Farrelly et al., 2013). Farrelly et al. (2013)
found that women with BRCA1/2 mutations expressed a high level of unmet support
needs, with almost half of the sample reporting at least six moderate to very high unmet
needs, while only 9% of the sample reported no unmet needs (Farrelly et al., 2013). The
most common unmet needs among the participants in this study included dealing with
uncertainty about the future and dealing with fears of developing cancer (Farrelly et al.,
2013). Interestingly, dealing with feelings of isolation was one of the least reported needs
identified by this population (Farrelly et al., 2013). Several predictors of unmet needs for
this population have also been identified, including shorter time since finding out about
mutation status and being of a younger age (Farrelly et al., 2013). Some studies of
survivors of breast cancer have reported a similar finding and have suggested that the
needs of young women often center around fertility, premature menopause, and general
impact on family planning (Thewes, Butow, Girgis, & Pendlebury, 2004; Thewes et al.,
2005). Similar needs may be present in young women with BRC1/2 mutations because of
the decisions that they need to make regarding risk-reducing surgeries (Farrelly et al.,
2013).
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Body Image
Women in general are concerned with their weight, appearance, and body (Helms,
O’Hea, & Corso, 2008). One study suggests that 89% of women in the general population
report concern with weight (Cash, Melnyk, & Hrabosky, 2004). Body image is an overall
attitude toward one’s body and is made up of how one evaluates oneself, as well as how
much investment one puts into one’s body image to determine one’s satisfaction,
happiness, or well-being (Helms et al., 2008). Stokes and Frederick-Recascino (2003)
added that body image reflects a direct personal perception and self-appraisal of one’s
physical appearance, whereby negative thoughts and feelings related to one’s body
indicate a disturbance of body image and lead to dissatisfaction with oneself. Body image
is defined as the mental picture of one’s body; and an attitude about the physical self,
appearance, and state of health, wholeness, normal functioning, and sexuality (Fobair et
al., 2006). Body image is a component of a larger concept of self that, for women,
includes feeling feminine and attractive (Carver et al., 1998; Cohen, Kahn, & Steeves,
1998; Hopwood, 1993; Mock, 1993; White, 2000). Additionally, Kullmer et al. (1999)
added that body image is considered to be the sum of state of health, body care and outer
appearance.
Body image is a complex, multidimensional construct that involves perceptions,
thoughts, and feelings about the whole body and its functioning (Fingeret et al., 2014).
This construct has been identified as a critical psychosocial issue for patients with cancer
undergoing reconstructive surgery because they are at a high risk of experiencing bodily
changes and disfigurement, as well as functional impairment (Fingeret et al., 2014). The
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process of adjusting to bodily changes associated with reconstructive treatment is not
static, but ongoing, as multistage procedures are often required (Fingeret et al., 2014), as
is the case with women with BRCA1/2 mutations who choose to undergo a PBM. Interim
outcomes may be particularly difficult for patients when cosmetic form and function have
not yet been fully restored (Fingeret et al., 2014). A study that examined patients with
early-stage breast cancer found that “concern about appearance” related to emotional
distress and that “concern about body integrity” related to three other indices of wellbeing: greater loss of the sense of attractiveness and sexual desirability, greater disruption
of social activities, and greater endorsement of an item assessing an alienation or
estrangement from the self (Carver et al., 1998). This finding suggests that different
components of body image allude to difficulties in a variety of areas in terms of
psychosocial and physical functioning.
Unfortunately, little, if any, research has been conducted on the body image
concerns that women with BRCA1/2 mutations experience. High rates of body image
concerns have been documented for patients with head, neck, and breast cancers patients;
these groups of patients are those who most often undergo reconstructive surgery
(Fingeret et al., 2014). Body image disturbance is among the most common psychosocial
concern reported by women with breast cancer (Fingeret et al., 2014), and as many as
75% of patients with head and neck cancers have also reported similar concerns (Fingeret
et al., 2014). In a study that examined body image in adolescents with medical illnesses,
Meissner (1997) found that physical problems of high impact and visibility have the
greatest impact on body image. Interestingly, Pendley, Dahlquist, and Dreyer (1997)
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found that in adolescent survivors of cancer, body image concerns, such as negative body
image perceptions, did not develop until several years post treatment. These findings
suggest that, especially for women with BRCA1/2 mutations who often undergo a
lengthy and difficult reconstructive process post PBM (Friedman et al., 2012), body
image may be affected by the preventative options chosen by the individual.
Breast cancer and body image. The 1987 Psychological Aspects of Breast
Cancer Study Group (Pinto, Clark, Maruyama, & Feder, 2003) found that patients with
breast cancer demonstrated self-deprecation, inadequate body image, and weight gain.
These difficulties have continued to be characteristic in more recent studies of women
with breast cancer. Przezdziecki et al. (2013) found that a considerable number of women
reported experiencing body image disturbance related to their breast cancer diagnosis and
treatment, a finding consistent with other studies reporting sustained body image
difficulties at 12 months post diagnosis and beyond (Falk-Dahl, Reinertsen, Nesvold,
Fossa, & Dahl, 2010; Hartl et al., 2010). The women in this sample expressed levels of
body image disturbance greater than those reported in Hopwood, Fletcher, Lee, and
Ghazal (2001) when they were validating the Body Image Scale. However, the women in
the Przezdziecki et al. (2013) study had a longer time since diagnosis than the women in
Hopwood et al. (2001), suggesting sustained body image disturbance (Przezdziecki et al.,
2013). Therefore, one cannot assume that body image disturbance experienced by
survivors of breast cancer will necessarily diminish with time (Przezdziecki et al., 2013).
The potential for sustained body image disturbance especially significant considering the
link between body image disturbance and self-esteem, with self-esteem serving as a
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protective factor to the experience of distress and as a correlate to feeling supported by
family and friends (Fobair et al., 2006).
Mastectomy and body image. Some of the most important factors affecting a
woman’s decision to have a lumpectomy and radiation versus a mastectomy to treat her
breast cancer include anticipated negative effects on body image, anticipated
disfigurement, and expected loss of femininity post surgery (Margolis, Goodman, Rubin,
& Pajac, 1989), all of which are realistic concerns. The negative impact of mastectomy is
well documented (Polivy, 1977), which is no surprise considering that mastectomy is an
amputation that disturbs body image and alters sexual relationships for a significant
period of time (Sheppard & Ely, 2008). In addition to altering body image and sexual
relationships, mastectomy may also induce significant levels of psychological distress,
although breast reconstruction may lead to early restoration of physical health (AlGhazal, Fallowfield, & Blamey, 2000; Fobair et al., 2006; Ganz et al., 1996; Ganz,
Desmond, Belin, Meyerowitz, & Rowland, 1999; McGaughey, 2006). However, whether
the impaired psychological functioning is the consequence of the mastectomy or of the
breast cancer diagnosis itself is debatable (Metcalfe et al., 2004).
Several studies compared women who chose to have a mastectomy with those
who chose breast conservation treatment options for breast cancer and found that women
who chose to undergo a mastectomy were more likely to report body image
dissatisfaction than those who chose breast conservation treatment options (Arora et al.,
2001; Avis, Crawford, & Manuel, 2004; Beckman, Johansen, Richardt, & Blickert-Toft,
1983; Ganz, Lee, Sim, Polinsky, & Schag, 1992; Lee et al., 1992; Schain, D’Angelo,
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Dunn, Lichter, & Pierce, 1994; Polivy, 1977; Taylor et al., 2002; Yurek, Farrar, &
Andersen, 2000). Mock (1993) compared body image in women receiving different types
of breast cancer treatments. In this study, significant differences in body image were
found according to type of surgical treatment experienced. While body image was poorer
in all subjects with breast cancer compared to healthy individuals, those who received
conservative surgical treatment reported greater satisfaction with their bodies than those
treated with either mastectomy or immediate reconstruction (Mock, 1993). Another study
examined the relationship between cosmetic appearance of the breast after breast
conservation surgery and psychological well-being (Al-Ghazal, Fallowfield, & Blamey,
1999). This study found a significant correlation between cosmetic outcome and
depression, as well as body image (Al-Ghazal et al., 1999). These results suggest that the
deformed physical appearance of a woman’s breast post surgery affects her mood, as well
as her feelings about herself and her view of her body (Al-Ghazal et al., 1999).
Considerable evidence shows that survivors of breast cancer may experience
prolonged psychological distress, especially in terms of perception of their physical
appearance and body image (Scott, Halford, & Ward, 2004), even though treatment has
ended and the woman may be medically well (Przezdziecki et al., 2013). This prolonged
psychological distress may be related to the finding that women with breast cancer have a
particularly hard time adjusting to the disease and treatment, which are associated with
significant alterations in body image and sexuality (Baucom, Porter, Kirby, Gremore, &
Keefe, 2005; Bredin, 1999; Geiger et al., 2006; McGaughey, 2006; Schover et al., 1995).
Some research suggests that this population struggles with self-compassion, which serves
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as a protective factor for body image disturbance and psychological stress (Przezdziecki
et al., 2013), and with self-consciousness, which appears to compound body image
disturbances (Brandberg et al., 2008).
PBM and body image. Breast surgery involving partial or complete loss of one
or both breasts may result in poorly aligned breasts and breast asymmetry, extensive
scarring and alteration to the breast and/or nipple sensation, need for a breast prosthesis,
possible changes to limb mobility, and lymphedema (Anderson & Johnson, 1994; CraneOkada, Wascher, Elashoff, & Giuliano, 2008; Kadela-Collins et al., 2011; Swenson et al.,
2002; Vadivelu, Schreck, Lopez, Kodumundi, & Deepak, 2008). These risks may also be
true of women who chose surgery as a preventative option because of high-risk status.
Women who choose to undergo a PBM often report being satisfied with their decision
(Bresser et al., 2006; Frost et al., 2000; Metcalfe et al., 2004) despite findings from
several studies that concluded that a substantial proportion of women reported body
image problems post PBM (Anderson & Johnson, 1994; Borgen et al., 1998; Brandberg
et al., 2008; Crane-Okada et al., 2008; Frost et al., 2000; Kadela-Collins et al., 2011;
McGaughey, 2006; Swenson et al., 2002; Vadivelu et al., 2008), some of whom
experienced body image disturbance after 1 year (Brandberg et al., 2008; Lodder et al.,
2002). In a study of 370 women by Payne, Biggs, Tran, Borgen, and Massie (2000), 5%
of the women reported regrets about their decisions. While there were six major reasons
for this regret, two reasons were directly related to body image: dissatisfaction with the
cosmetic effect of surgery and diminished self-image or sexual satisfaction (Payne et al.,
2000). Six of the women who reported regret described having marked concerns about
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their body image, 16 of the same grouping of women reported a lack of breast sensation,
body image issues, and difficulty with clothing, and three additional women reported
disfiguring scars (Payne et al., 2000). This study suggests that, for a portion of those who
experience regret after PBM, body image dissatisfaction may play a role. However, the
specifics of the surgeries (e.g., type of PBM, type of reconstruction) were not noted in
this study, which is significant considering the notion that the more drastic and invasive
the breast surgery is, the more it will affect a woman’s sense of cosmetic satisfaction and
psychological well-being (Al-Ghazal et al., 2000).
In contrast, some studies have suggested that the majority of women who undergo
PBM experience only minor alterations in body image (Hopwood et al., 2000), while
others have suggested that this population does not experience body image disturbance
(Hatcher et al., 2001). Josephson, Wickman, and Sandelin (2000) found that 13 of 15
women felt that their body image was better than they had expected post PBM.
Additionally, some research has found that more than 50% of those examined reported no
changes in satisfaction in their appearance (Frost et al., 2000; Metcalfe et al., 2004). Den
Heijer, Seynaeve, Timman et al. (2012) suggested that the mixed findings regarding
levels of body image disturbance experienced by those who have undergone PBM may
not be accurate because many of the observations were obtained from retrospective
studies for which information on women’s body image prior to PBM is not available, and
consequently, changes in body image specifically as a result of PBM could not be
assessed. Similarly, Brandberg et al. (2008) offered a possible alternative explanation for
the low levels of body image disturbance found in the population of this study: Those
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who failed to complete the 1-year follow-up assessment tended to report higher levels of
body image disturbance 6 months post PBM. Thus, the result at the 1-year assessment
might be an underestimation of the body image problems experienced by the sample
(Brandberg et al., 2008). Den Heijer, Seynaeve, Timman et al. (2012) added that a
follow-up period of 1 year may be too short to capture the assimilation of reconstructed
breasts into a woman’s body image, as the reconstruction process often takes several
months, depending on the reconstruction technique used.
Den Heijer, Seynaeve, Timman et al. (2012) explored the course of psychological
distress and body image at long-term follow-up (6-9 years) after PBM and breast
reconstruction in women at risk for HBOC. Researchers found that general body image
before PBM was predictive of general body image long term after PBM (Den Heijer,
Seynaeve, Timman et al., 2012; Hatcher et al., 2001; McGaughey, 2006); interestingly,
women’s breast-related body image before PBM did not predict for breast- related body
image after PBM (Den Heijer, Seynaeve, Timman et al., 2012). Additionally, Den Heijer,
Seynaeve, Timman et al. (2012) found that in the first 6 months post PBM, women
reported a significant increase in problems with breast-related and general body image.
One study suggested that increase in body image disturbance in this population could be
caused by concerns over the influence of one’s BRCA1/2 status on their intimate partner
relationship (Beran et al, 2008).
Self-Concept
Baumeister (1998) described self-concept as the interpretation and enactment of
the idea of self in the environment. Blascovich and Tomaka (1991) further explained that
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self-concept is composed of cognitive, behavioral, and affective components. The
behavioral component is an aspect of the self that is observable to others, while the
cognitive component is an aspect of self that is internal and private (Marsh & Hattie,
1996). The affective component of the self consists of evaluative components of the self
(e.g., good or bad; Harter, 1996); this component is more commonly referred to in the
literature on self-concept as self-esteem (Blascovich & Tomaka, 1991). McConkie-Rosell
and DeVillis (2000) concluded that self-concept is the representation of the self based on
the integration of these behavioral, cognitive, and affective components.
Specifically in terms of the cognitive component of self-concept, the schema
model of self-concept (Cella et al., 2002; Markus & Keith, 1982; Markus & Wurf, 1987;
Stein, 1995) best describes this component. According to this perspective, one’s
responses to the environment are mediated through internal structures, or self-schema,
that work together to form a person’s self-concept (Esplen et al., 2011). Schemas are
derived from experiences (Cervone & Pervin, 2008), are content specific, and can also be
formed through internalized cultural values and norms (Rodin, Silberstein, & StreigelMoore, 1985). Self-schemas actively integrate, shape, and summarize perceptions and
experiences; self-schemas are the lens through which people view and interpret the world
(Markus & Keith, 1982, and can be developed about any aspect of a person, including
body weight (Markus, Hamill, & Sentis, 1987), exercise (Kendzierski, 1988), and sex
roles (Markus & Keith, 1982). Individuals who have a positive perception of the self are
better able to cope with threat, loss, and misfortune, as compared to those with a more
negative self-concept (Baumeister, 1998). Interestingly, self-concept can influence
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motivations to adopt screening or engage in health-protective behaviors, as well as
influence reactions and abilities to cope with negative life situations (Devins, Beanlands,
Mandin, & Paul, 1997; Stein, 1995).
Both body image and self-concept develop during childhood and adolescence and
undergo constant changes throughout the lifespan (Kullmer et al., 1999). Markus and
Wurf (1987) suggested that self-concept has different components: a working selfconcept, which may be the portion of self-concept that is more amenable to change, and
core components of self-concept (e.g., self-schema) that remain relatively stable over
time and throughout experiences. Foltz (1987) presented a set of components of selfconcept, including the bodily self (i.e., physical function and body image), the
interpersonal self (e.g., psychosocial and sexual interaction), the achievement self (e.g.,
job role function), and the identification self (e.g., spiritual and ethical beliefs). These
components in particular are likely related to self-schema, as the schema model of selfconcept suggests (Cella et al., 2002; Stein, 1995; Markus & Keith, 1982; Markus &
Wurf, 1987). Additionally, Kullmer et al. (1999) suggested that self-concept is the sum of
a person’s feelings about the self, with five major, interrelated elements, all of which may
be affected during the diagnosis and treatment of cancer: (a) alteration in bodily
experience, (b) discrepancy between actual and ideal self, (c) disruption of personal
relationships, (d) self-deprecating meaning of cancer, and (e) depression.
Breast cancer treatment and self-concept. In everyday life, focus on the self is
not common (Denieffe & Cooney, 2010). However, an illness such as breast cancer
disrupts the unity of the body and the self and may cause disruptions within one’s self-
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concept (Baron, 1985). The potential for damage that breast cancer and its treatment pose
is relatively obvious (Foltz, 1987). The impact of a cancer diagnosis may threaten
fundamental beliefs, role interpretations, and role functions, with cancer treatment
influencing additional aspects of self-concept (Foltz, 1987). For example, surgery entails
a defect, whether visible or not, requiring alteration in the view of the self (Foltz, 1987).
The impact of breast cancer on the self occurs over time; treatments for breast cancer are
accompanied by physical, psychological, and social symptoms that in turn affect selfconcept (Denieffe & Cooney, 2010). Denieffe and Cooney (2010) found that women
perceived breast cancer as a challenge to their sense of self, their existence, and their
future goals and personal values. Charmaz (1999) added that this challenge is often the
result of illness immersion, which involves the illness permeating all areas of life; the
significant impact and changes associated with illness immersion possibly suggest that
one’s self-concept has been altered as a result of cancer diagnosis and treatment
experiences.
Related to the aspects of self as identified by Foltz (1987), Curbow and
Somerfield (1991) added that individuals bring a precancer self-concept to the situation
that is unique in terms of configuration, content, and structure. However, the self-concept
shifts over time as patients become immersed in their treatments and recoveries (Curbow
& Somerfield, 1991) or as patients become immersed in their illness (Charmaz, 1999).
Once individuals cross over into the “cancer self,” they may begin to share more content
and structure with others in similar situations as themselves (Curbow & Somerfield,
1991). Aspects of cancer (e.g., uncertainty of etiology and course) and cancer treatment
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(e.g., multiple therapies, surgeries) serve to make patients particularly vulnerable to
changes in their self-concept (Curbow & Somerfield, 1991). Mages and Mendelsohn
(1979) added that the physical damage and changes that often accompany breast cancer
treatment may force changes in self-concept. More specifically, women who lose one or
both of their breasts as a result of cancer treatment may experience changes in their
identity, sexuality, and sense of self (Manderson & Stirling, 2007), with approximately
one third of survivors of breast cancer expressing distress directly related to body image
after successful cancer treatment (Scott et al., 2004).
Zebrack (2000) explained that the diagnosis and treatment for cancer lead to the
development of a new social role - the role of the cancer survivor - which persists
throughout one’s life. Cancer is not an acute event with a definite ending, but instead it is
a process that extends for the rest of the lifespan (Bowman, Deimling, Smerglia, Sage, &
Kahana, 2003; Clark & Stovall, 1996). Heigeson (2011) examined the extent to which
10-year survivors of breast cancer integrated cancer into their self-concepts (i.e., survivor
centrality). These researchers found a moderate amount of survivor centrality in survivors
of breast cancer which is consistent with the perspective that cancer is not an acute, timelimited phenomenon but instead a process that extends throughout the lifespan (Bowman
et al., 2003; Clark & Stovall, 1996). Heigeson (2011) also found that younger women
were more likely than older women to define themselves in terms of breast cancer
survivorship, perhaps because the incongruence between the experience of a lifethreatening illness and young age is greater (Heigeson, 2011).
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Despite the lack of research on survivor centrality, healthcare professionals have
been long aware that the integration of an illness into one’s identity is a theme that
emerges from discussions with survivors of cancer (Heigeson, 2011). In a study of adult
survivors of childhood cancer, survivors frequently discussed the extent to which the
cancer came to identify themselves (Drew, 2007). In another study of adult survivors of
childhood cancer, some stated that they defined themselves in terms of the cancer and
saw it as an integral part of their sense of self (Prouty, Ward-Smith, & Hutto, 2006). In
another study, men and women with a history of cancer were interviewed, and issues of
identity and changes in identity were explored; for some individuals in this study,
survivorship was a core aspect of their identities (Little, Paul, Jordens, & Sayers, 2002).
Related to survivorship is the term previvorship, which refers to those who carry a
genetic mutation that predisposes them to various types of cancer, but have never been
diagnosed with cancer (Friedman et al., 2012). Interestingly, research on previvors (e.g.,
women who carry BRCA1/2 mutations who have not been diagnosed with cancer) and
the impact that their genetic status has had on their self-concepts shows various
similarities to the research on survivors of breast cancer and various chronic illnesses.
Women with BRCA1/2 mutations and self-concept. Any new information
about oneself can threaten an existing self-concept (McConkie-Rosell & DeVillis, 2000).
Additionally, the centrality of a person’s self-concept is maintaining physical and
psychosocial well-being (Devins et al., 1997; Kendzierski, 1988; Linville, 1987; Markus,
1977). Thus, not surprisingly, knowing that one is a carrier for a genetic disorder has the
potential to alter one’s self-concept (Schild, 1984), and more specifically, that women
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who learn they are at an increased risk of hereditary breast cancer experience alterations
in self-concept (Esplen et al., 2009; McConkie-Rosell & DeVillis, 2000). McConkieRosell and DeVillis (2000) reflected this concept in their discussion of a “genetic
identity,” which is a key aspect of identity theory. This term was first used by Schild
(1966), who described this term as the dimension of self-concept that develops from
one’s perception of one’s genetic inheritance. Carrier testing presents a potential threat to
self-concept because the accuracy of a DNA-based test makes the results particularly
difficult to refute (McConkie-Rosell & DeVillis, 2000). Additionally, carrier testing
represents a new and unplanned life event for most individuals (McConkie-Rosell &
DeVillis, 2000). If the outcome of genetic testing affects a dimension of importance to
the individual and cannot be refuted, learning this new information about self or family
could potentially threaten self-concept (McConkie-Rosell & DeVillis, 2000).
McConkie-Rosell and DeVillis (2000) suggested that learning new information
regarding genetic identity could have negative connotations resulting from one’s
perception of carrier status, including being inconvenient or discomforting or being
demanding or restricting in a variety of areas of life. Schild (1984) suggested that the
diagnosis of a genetic disorder could compromise self-concept to the point that healthy
adaptation to one’s carrier status may be affected. Hattie (1992) added that self-concept is
multidimensional and hierarchical. This nature suggests that the weight of importance
given to any one dimension varies uniquely as a function of the individual and societal
value placed on that particular dimension, and supports the further examination of a
component-based model of self-concept instead of a global model of self-concept in this
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population (Hattie, 1992). Lim, MacLurin, Price, Bennett, and Butow (2004) found that
some women with mutations experience a sense of “living with cancer” throughout their
lifetimes, despite not having been diagnosed with cancer. Among younger women, selfreports of “life-changing experiences” and a reevaluation of priorities have been observed
after being diagnosed as mutation positive (Hallowell, Foster, Eeles, Arden-Jones, &
Watson, 2004; Lim et al., 2004).
BRCA1/2, uncertainty, and self-concept. Several researchers have observed that
women with BRCA1/2 mutations commonly report changes in their perception of
themselves and speak of feeling “different” from their peers (Esplen et al., 2009). One
factor that may impact this self-perception is uncertainty of illness, which often
accompanies the initiation of BRCA1/2 testing in the first place (Mischel, 1988).
According to Mischel (1988), an inability to predict the outcome of one’s illness can
propel a patient into a state of uncertainty said to result from an inability to form a
cognitive schema of the illness. Shaha, Cox, Talman, and Kelly (2009) completed a metaanalysis of 40 studies pertaining to those already diagnosed with breast, prostate, and
colorectal cancer and found that many participants struggled with uncertainty; for
women, uncertainty toward their womanhood was specifically noted. Unlike in patients
fighting cancer, the very nature of BRCA1/2 mutations creates a kind of uncertainty,
which is almost impossible to minimize because one cannot tackle a potentiality that may
still lead to a fatal outcome (DiMillo et al., 2013). Even though these women live with
the possibility of developing breast cancer, their experiences mirror those of individuals
living with a chronic illness, and they must therefore adapt accordingly in a physical,
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psychological, and social manner (Samson et al., 2014). One of the aspects of uncertainty
that carriers of BRCA1/2 mutations must adapt to is the array of potential medical and
existential implications as a consequence of possessing this genetic mutation, including
the choice of whether to undergo PMB or ooperectomy (Klitzman & Chung, 2010).
DiMillo et al. (2013) found that women with BRCA1/2 mutations share many aspects of
the experiences described by women who have already been diagnosed with breast cancer
(Liao, Chen, Chen, & Chen, 2008; Warren, 2010), including living with uncertainty
(DiMillo et al., 2013).
Adjusting to the uncertainty of having a BRCA1/2 diagnosis is an important
component of psychological adjustment for this population (Den Heijer et al., 2011).
Psychological resources may play a crucial role in the adjustment to stressful life events,
as these resources may serve to buffer against the negative impact of such events (BenZur, 2002). For example, self-esteem is strongly associated with psychological
functioning and has been found to be associated with lower levels of depression and
higher levels of well-being in patients with cancer (Schroevers et al., 2003). Within
current models of self-concept, self-esteem is considered as the generalized evaluation of
the self and is only one dimension of the collection of cognitive representations that
makes up self-concept (Curbow et al., 1990). Therefore, general self-esteem may not be
the only aspect of self-concept that is relevant to well-being (Curbow & Somerfield,
1991). With the increased emphasis on the multidimensionality of self-concept (Marsh,
1986; Rosenberg, Schooler, Schoenbach, & Rosenberg, 1995), one must address the
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specific aspects of self-concept that are most vulnerable in women at risk of hereditary
breast cancer.
Potential impacts of being diagnosed as BRCA1/2 positive include feeling
stigmatized, alienated, different from others, and vulnerable (Esplen et al., 2009; Markel,
1992 Rosser, 1981). These altered self-schemata can play a role in health behaviors, lead
to psychological distress, and interfere with planning for one’s future (Linville, 1987;
Showers, 1992). Similarly, Esplen et al. (2009) suggested that the specific components of
self-concept most relevant to carriers of BRCA1/2 mutations and their well-being include
stigma, vulnerability, and mastery. Thus, these components of self-concept clearly are
vulnerable to alteration in carriers of BRCA1/2 mutations, but also pose a negative
impact once altered (Esplen et al., 2009; Linville, 1987; Showers, 1992; Markel, 1992;
Rosser, 1981). Hoskins et al. (2012) found that the most favorable outcomes in terms of
assimilating information about risk, arriving at a solid personal sense of cancer risk, and
making decisions about risk management were found in those who effectively understood
that they were not defined by their body parts or their genetic mutation. This cognitive
shift, possibly a reflection of a healthy and stable self-concept, brought easier acceptance
of the possible implications of their risk, including losing body parts via risk-reducing
surgeries (Hoskins et al., 2012).
The relationship between body image and self-concept. Petronis, Carver,
Antoni, and Weiss (2003) identified psychological investment in body image as a risk
factor for disruption after breast cancer treatment; this investment may influence the
degree of threat posed by breast cancer and its treatment. Many years ago, James (1890)
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explained that an investment in a particular aspect of the self can create a vulnerability to
distress if that aspect of self is threatened. Kullmer et al. (1999) found that gynecological
and breast cancers have a special impact on a woman’s self-esteem and body image, as
well as a significant impact on self-concept and body image in patients with
gynecological and breast cancer. Additional studies suggest that this impact can last a
long time, as demonstrated specifically for patients with breast cancer (Lasry &
Margolese, 1992; Taylor et al., 1995). Similarly, Helms et al. (2008) reported that breast
disfigurement after breast cancer can lead to marked psychological distress in women.
Effects of surgical procedures for breast cancer treatment can impact various areas of a
woman’s psychological functioning, including identity, confidence, mood, esteem,
sexuality, self-satisfaction, and quality of life (Helms et al., 2008).
Kraus (1999) compared body image satisfaction in women pre and post surgery
for breast cancer to that of women with a diagnosis of cancer and found greater body
satisfaction following surgery among women who had been less concerned about body
shape and size before surgery. Further, women who reported decreased bodily concerns
demonstrated stronger self-concepts and identities than the women who reported they
placed a high value on physical appearance (Kraus, 1999). Similarly, Helms et al. (2008)
found that the less significant the body image concerns, the more stable the self-concept
throughout the process of PBM. Since the breast is one aspect of a woman’s overall sense
of femininity and body image, disruption of its appearance causes upset in a woman’s
emotional well-being and self-concept as a whole (Helms et al., 2008; Vaeth, 1986).
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Body image as a component of self-concept. Mock (1993) found a positive
correlation between body image and self-concept, thus supporting the notion that body
image is an integral component of self-concept. Self-concept themes in the body image
domain include altered breasts and breast sensation, mistrust of body, loss of sensation or
function, feeling older, loss of reproductive functioning, impacts of early menopause,
weight gain, and altered body shape, all of which are issues faced by women with
BRCA1/2 mutations (McGaughey, 2006; Hallowell, Mackay, Richards, Gore, & Jacobs,
2004). Fitts and Warren (1996) described body image as a mental picture of the physical
self that includes attitudes and perceptions regarding one’s physical appearance, state of
health, skills, and sexuality. Mock (1993) asserted that body image is an integral part of
self-concept, which is the total perception an individual holds of the self. As a composite
of one’s physical, personal, social, and moral-ethical self, self-concept influences the way
an individual perceives the world and interacts with it (Fitts, 1971).
An understanding of body image as a component of self-concept provides a
framework for studying the responses of women to treatment for breast cancer, as these
responses reflect the importance of the female breast as a symbol of womanliness, sexual
attractiveness, and nurturance (Mock, 1993). Loss of a body part that is significantly
related to feminine identity may result in a negative alteration in body image and selfconcept (Mock, 1993). The degree of negative alteration may be expected to be
correlated with the degree of physical change in the body and with the meaning of the
body part to the individual (Mock, 1993). While this research pertains to women who are
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undergoing treatment for breast cancer, this research may extend to women without
cancer who are BRCA1/2 positive and going through PBM.

55

BRCA1/2, SELF-CONCEPT, AND BODY IMAGE

56

Chapter 2: Research Question and Hypotheses
Research Question
How do women with deleterious BRCA1/2 mutations who choose to undergo a
prophylactic bilateral mastectomy compare to those who use surveillance methods differ
on measures of body image and self-concept?
Hypotheses
Hypothesis 1a
Women with deleterious BRCA1/2 mutations who have undergone prophylactic
bilateral mastectomies will display greater investment in appearance on a measure of
body image when compared to women with deleterious BRCA1/2 mutations who engage
in surveillance methods.
Hypothesis 1b
Women with deleterious BRCA1/2 mutations who have undergone prophylactic
bilateral mastectomies will display greater investment in body integrity on a measure of
body image when compared to women with deleterious BRCA1/2 mutations who engage
in surveillance methods.
Hypothesis 2a
Women with deleterious BRCA1/2 mutations who have undergone prophylactic
bilateral mastectomies will report greater experiences of stigma on a measure of selfconcept when compared to women with deleterious BRCA1/2 mutations who engage in
surveillance methods.
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Hypothesis 2b
Women with deleterious BRCA1/2 mutations who have undergone prophylactic
bilateral mastectomies will report greater experiences of vulnerability on a measure of
self-concept when compared to women with deleterious BRCA1/2 mutations who engage
in surveillance methods.
Hypothesis 2c
Women with deleterious BRCA1/2 mutations who have undergone prophylactic
bilateral mastectomies will report fewer mastery experiences on a measure of selfconcept when compared to women with deleterious BRCA1/2 mutations who engage in
surveillance methods.
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Chapter 3: Methodology
Design and Design Justification
This study examined women with deleterious BRCA1/2 mutations who chose to
use surveillance methods only, as well as those who chose to undergo a prophylactic
bilateral mastectomy (PBM) in an effort to prevent the future occurrence of breast cancer.
These women were compared in regard to proposed differences that they may have
presented in terms of body image and self-concept. A between-subjects approach was
used for this study, as differences between groups were examined at a single point in
time.
Recruitment of Participants
The participants were recruited through online postings dispersed by the
investigator. Primary recruitment resources included posts made on the following
Facebook support groups that target women at high risk for cancer as a result of genetic
mutations: YP’s Surveillance Sisters (posted January 27, 2018), Young Previvors (posted
January 27, 2018), BRCA Sisterhood (posted January 31, 2018), Mutant Strong (posted
February 11, 2018), BRCA Genetic Sisters Awareness Page (posted February 11, 2018),
BRCA Advanced 101/102 Journal Club (posted February 11, 2018), and this
investigator’s personal Facebook page (posted January 27, 2018). Before posting on these
pages, the investigator elicited administrator permission to post on each of these sites.
Potential participants received a link to the online survey, as well as information
describing the study and the inclusion requirements for an individual to be eligible for
participation. Participation in this study was voluntary, but those who completed the
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survey had the choice to be entered into a raffle to win one of three available $50
Amazon gift cards. The following recruitment message was posted to help in recruiting
individuals to participate in this study:
My name is Amanda Large, and I am a doctoral candidate in the APA-accredited
program in Clinical Psychology at the Philadelphia College of Osteopathic
Medicine. Under the supervision of Dr. Barbara Golden, Psy.D., ABPP, Professor
and Principal Investigator, you are invited to participate in this study through
which I am collecting information for my dissertation. This study will help us to
more fully understand how being BRCA1/2 positive impacts how women view
and think about themselves and their bodies. In order to participate in this study,
you must be 18 years old or older, be able to read and understand English, have
access to an electronic device on which to take the survey, and possess a
deleterious BRCA1/2 mutation. All information you provide will be anonymous
and confidential, you can withdraw from the study at any time, and your
responses to the survey will not be tied to any personal information. By answering
these questions, you may find out some things about yourself that you did not
know previously, and it is possible that in some people, this may cause mild
emotional discomfort. This survey will take 20-30 minutes to complete. When
you are finished taking the survey, you will have the opportunity to send an email
to an independent email address to enter your email in a drawing to win a $50
Amazon gift card. Your email address will not be linked to information you
provide throughout the course of the survey. If you are interested in participating,
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please click the following link: https://www.surveymonkey.com/r/R7P6VDK.
Should you have any questions, please feel free to contact Dr. Golden at
barbarago@pcom.edu. This study has been approved by the Philadelphia College
of Osteopathic Medicine Institutional Review Board (protocol approval # H17054X). Thank you in advance for your time and assistance.
This study was anonymous and connecting the identity of a participant to her
responses was not possible. As such, informed consent was not required. However,
prospective subjects were provided the opportunity to decide whether or not to participate
in the study after they had read the information included in the posting and before they
were provided with the link to the survey. The prospective participants were informed
that (a) this study was designed to them help more fully understand how being BRCA1/2
positive impacts women’s views and thoughts about themselves and their bodies, (b)
participation was anonymous, (c) participation was completely voluntary, (d) they could
withdraw participation at any time without consequences, and (e) no major risks to
participating were expected, although they may experience mild emotional discomfort.
Before beginning the study, a power analysis was conducted and determined that
212 participants were needed to complete this study. Assuming that 30% of those
participants came through, an estimated700 participants maximum could be involved.
This power analysis is characterized by a medium effect size with 80% power at a .05
level of significance. There were two comparison groups and five dependent variables.
In order to participate in this study, potential participants had to be women older
than the age of 18 years who reported having been diagnosed with a deleterious
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BRCA1/2 mutation. Potential participants had to be able to read and understand English,
as well as to have access to an electronic device on which the online survey could be
accessed. Potential participants could not participate in the study if they were younger
than 18 years of age, could not read and understand English, did not have access to an
electronic device and the Internet, and did not have a deleterious BRCA1/2 mutation. A
screener was built into the only survey to screen out those who did not meet inclusion
criteria.
Measures
Demographic Information Questionnaire
The Demographic Information Questionnaire was designed for the purpose of
gathering information relevant to this study. Information was gathered on participant
demographics (e.g., age, marital status), BRCA1/2 diagnosis, chosen preventative
pathway for breast cancer risk (e.g., PBM, surveillance, other), personal and familial
cancer history, and various other variables related to the experience of having a
BRCA1/2-positive diagnosis.
The Measure of Body Apperception (MBA)
The MBA is an eight-item measure (plus two filler items) designed to assess
investment in and concern about body apperception in patients with breast cancer (JeanPierre et al., 2012). The MBA is a measure of the investment in, or dependence on, one's
body image as a source of self-worth; it has two scales, which reflect investment in
physical appearance and investment in a sense of body intactness or integrity (Carver,
2013). Initial validation of the MBA revealed a multidimensional or two-factor measure
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that explained 52.2 % of the variance (Carver et al., 1998). Test–retest of the MBA
revealed a correlation of r = 00.75 for each subscale over a period of 4 weeks (Carver et
al., 1998). Participants responded to the 10 items of the MBA on a 4-point Likert scale
that ranged from 1 (I disagree a lot) to 4 (I agree a lot; Carver, 2013). A total scale score
was calculated by summing all the items of the MBA, and two subscales were calculated
by calculating all of the items on each of these scales (Carver, 2013). The Investment in
Appearance subscale includes Items 1, 3, 6, and 8, and the Investment in Body Integrity
subscale includes Items 2, 4, 7, and 9 (Carver, 2013). A higher score indicated a stronger
agreement with the MBA and a greater difficulty or disturbance in body image (JeanPierre et al., 2012).
The BRCA Self-Concept Scale (BSCS)
The BSCS assesses the impact of being a carrier of BRCA1/2 mutations on selfconcept (Esplen et al., 2009). It consists of 17 items with Likert responses ranging from 1
(strongly disagree) to 7 (strongly agree) in ascending order, with a score of 8
corresponding to the not applicable (NA) category (Esplen et al., 2009). Three main
factors are examined by this measure: Stigma, Vulnerability, and Mastery (Esplen et al.,
2009). The Stigma subscale contains Items 5, 8, 9, 10, 12, 13, 16, and 17. Cronbach’s
alpha of the Stigma subscale was 0.87, with a mean interitem correlation of 0.45 (Esplen
et al., 2009). The Vulnerability subscale includes Items 3, 4, 7, 11, and 14. Cronbach’s
alpha of the Vulnerability subscale was 0.76, with a mean interitem correlation of 0.38
(Esplen et al., 2009). The Mastery subscale includes Items 1, 2, 6, and 15. Cronbach’s
alpha of the Mastery subscale was 0.68, with a mean interitem correlation of 0.35 (Esplen
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et al., 2009). Higher scores on Stigma and Vulnerability imply negative changes in selfconcept, whereas a higher score on Mastery implies positive changes in self-concept
(Esplen et al., 2009).
Procedure
Investigators created an online survey on SurveyMonkey to include a screener for
inclusion criteria, the questions in the Demographic Information Questionnaire, MBA,
and BSCS. After soliciting administrator permission, the investigator posted the survey
link with accompanying solicitation statement on several Facebook support groups
geared toward women at high risk of cancer as a result of genetic mutations. If a
participant met the inclusion criteria, she was asked to agree to participate and was then
permitted to complete the Demographic Information Questionnaire. Prior to filling out
the online Demographic Information Questionnaire, participants reviewed a solicitation
statement outlining the nature of the Demographic Information Questionnaire. Each
individual was informed that participation was voluntary and that she was welcome to
discontinue filling out the Demographic Information Questionnaire at any point without
consequence. Those who did not meet eligibility criteria were informed of such and were
sent to a page at the end of the Demographic Information Questionnaire thanking them
for offering to participate. Participants who completed the Demographic Information
Questionnaire were directed to another page where they could choose to submit their
personal information for a chance to win one of three available prizes (i.e., $50.00
Amazon gift cards). This information was kept separate from the data acquired during the
completion of the Demographic Information Questionnaire to ensure that anonymity was
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maintained. Once all data collection was complete, the data were entered into an SPSS
data set and analyzed using SPSS.
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Chapter 4: Results
In this section, the results of the current investigation are presented. First, the
demographic characteristics of the same are described. Second, descriptive statistics for
each of the major variables are reported. Finally, the findings for each hypothesis tested
are described.
Demographic Characteristics of the Sample
To investigate the differences in body image and self-concept among women
diagnosed with deleterious BRCA1/2 mutations, a sample of volunteer participants was
collected using an online survey created on SurveyMonkey and posted on various
Facebook support groups geared toward women at high risk of cancer as a result of
genetic mutations. A total of 358 participants completed the online survey. An analysis of
demographic information for all individuals who completed the online survey was
conducted and is shown in Table 1. If an individual withdrew from the study before
completing all sections of the survey, her information was not collected or included in the
final results obtained from SurveyMonkey. When there was evidence of missing data or
failure to meet inclusion criteria, participants were omitted from the data analysis. Of the
358 participants who completed the survey, all were female, fluent in English, and had
been diagnosed with a deleterious BRCA1/2 mutation. With regard to age, 128
respondents fell within the 35- to 44-year range (35.8%). The remainder of participants
fell within the various other age groupings, ranging from ages 18 through 75 years. A
total of 261 of the women were married (72.9%), and 195 reported having at least one
child under the age of 18 years (54.5%).
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In terms of cancer diagnosis, 22 of the participants reported having a current
diagnosis of cancer (6.1%), with 105 participants reported having a history of cancer
diagnosis (29.3%). When asked about family history of cancer, 323 participants reported
having a family history of breast cancer (35.3%), and 186 reported a family history of
ovarian cancer (20.3%), which is consistent with the BRCA1/2 population. In terms of
prevention methods, 247 participants reported having previously undergone a
prophylactic bilateral mastectomy (PBM; 69%). The most common surveillance methods
used by participants included breast self-exams (31%) and clinical breast exams (28.7%),
with breast magnetic resonance imaging (MRI; 8.9%) and mammograms (12%) being
less common. This information on chosen surveillance methods makes sense when
considering that most participants had undergone a PBM, as the surveillance methods
common for those who have undergone this surgery are self and clinical breast exams,
with breast MRI and mammograms being more common among those who have not had
a PBM.
In summary, a review of the demographic data revealed that the sample contained
a set of participants that is likely an accurate representation of the general BRCA1/2
population. All respondents were female English speakers who had a diagnosis of a
deleterious BRCA1/2 mutation. Most women were married with children, had undergone
a PBM, and engaged in active surveillance methods. Participation in this study was
voluntary, and all participant information was kept anonymous.
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Table 1
Demographic Characteristics of the Sample

Age (years)

Response
18-24
25-34
35-44
45-54
55-64
65-74
Total

Frequency
13
94
128
74
41
8
358

Valid
percent
3.6
26.3
35.8
20.7
11.5
2.2
100.0

Gender

Female
Total

358
358

100.0
100.0

English Fluency

Yes
Total

358
358

100.0
100.0

Deleterious BRCA1/2 mutation Yes
Total

358
358

100.0
100.0

Relationship status

Married
Widowed
Divorced
Separated
Domestic partnership
Single but cohabitating
Single never married
Total

261
1
21
4
9
25
37
358

72.9
0.3
5.9
1.1
2.5
7.0
10.3
100.0

Children

18 yrs. and older
1 yr.+ under 18 yrs.
Currently pregnant
No
Total

72
195
1
90
358

20.1
54.5
0.3
25.1
100.0

Current cancer diagnosis

Yes
No
Total

22
336
358

6.1
93.9
100.0
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Chemotherapy
Radiation
Mastectomy
Lumpectomy
Other
Total

History of cancer diagnosis

68
11
4
37
1
40
93

3.1
1.1
10.3
0.3
11.2
26.0

Yes
No
Total

105
253
358

29.3
70.7
100.0

History of cancer treatment

Chemotherapy
Radiation
Mastectomy
Lumpectomy
Other
Total

67
44
117
40
33
301

22.3
14.6
38.9
13.3
10.9
100.0

Family history of cancer

Breast
Ovarian
Gynecological
Melanoma
Pancreatic
Colon
Lung
Other
Total

323
186
58
78
77
49
72
73
916

35.3
20.3
6.3
8.5
8.4
5.3
7.9
8.0
100.0

Identification as previvor

Yes
No
Unsure
Total

233
105
20
358

65.1
29.3
5.6
100.0

Current surveillance methods

Breast self- exam
Clinical breast exam
Breast MRI
Mammogram
Other
None of the above
Total

201
186
58
78
77
49
649

31.0
28.7
8.9
12.0
11.9
7.5
100.0

Current chemoprevention

Yes

16

4.5
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History of PBM

69

No
Total

342
358

95.5
100.0

Yes
No
Total

247
111
358

69.0
31.0
100.0

Future PBM
Yes
103
28.8
No
214
59.8
Undecided
41
11.5
Total
358
100.0
________________________________________________________________________
*PBM = prophylactic bilateral mastectomy

Descriptive Statistics
Participants responded to each item on the BRCA Self-Concept Scale (BSCS)
using a 7-point Likert scale. Responses on this scale include 1 (strongly disagree), 2
(disagree), 3 (somewhat disagree), 4 (neither agree nor disagree), 5 (somewhat agree), 6
(agree), and 7 (strongly agree) in ascending order, with a not applicable (NA) category.
Participants responded to each item on the Measure of Body Apperception (MBA) using
a 4-point Likert scale. Responses on this scale include 1 (I disagree a lot), 2 (I disagree a
little), 3 (I agree a little), and 4 (I agree a lot). To examine the distribution of responses
across the rating scale levels, frequency distributions for each item on each of these
scales were conducted and visually inspected. The data are not reported here; however,
the frequency distributions revealed variability across the rating points for all individual
items within each scale. Although the proportion of participants who selected a rating
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varied, each of the rating scale points was endorsed by different proportions of
individuals.
Descriptive statistics including means and standard deviations for each item on
the BSCS were examined. Cronbach’s alpha for the BSCS equaled .887. Cronbach’s
alpha for the Stigma subscale of the BSCS equaled .838. Cronbach’s alpha for the
Vulnerability subscale of the BSCS equaled .783. Cronbach’s alpha for the Mastery
subscale of the BSCS equaled .641. These values are acceptable in demonstrating the
internal consistency of the BSCS total scores and subscales. Descriptive statistics
including means and standard deviations for each of the items on the MBA were also
examined. Cronbach’s alpha for the MBA equaled .747. Cronbach’s alpha for the
Investment in Appearance subscale of the MBA equaled .744. Cronbach’s alpha for the
Investment in Body Integrity subscale of the MBA equaled .661. These values are
acceptable in demonstrating the internal consistency of the BSCS total scores and
subscales.
Hypothesis Testing
To test Hypotheses 1a and 1b, a MANOVA was conducted. To test Hypotheses
2a, 2b, and 2c, a separate MANOVA was conducted.
Hypotheses 1a and 1b
Hypothesis 1a predicted that women with deleterious BRCA1/2 mutations who
had undergone PBMs would display greater investment in appearance on a measure of
body image when compared to women with deleterious BRCA1/2 mutations who had
chosen to use surveillance methods only. Hypothesis 1b predicted that women with
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deleterious BRCA1/2 mutations who had undergone PBMs would display greater
investment in body integrity on a measure of body image when compared to women with
deleterious BRCA1/2 mutations who had chosen to use surveillance methods only.
There were two levels of the independent variable (PBM with and without
surveillance vs. no PBM with use of surveillance methods). The dependent variables
were investment in appearance and investment in body integrity. The dependent variables
were correlated, r(354) = 37, p = .000, which permitted the use of MANOVA. The means
and standard deviations by condition are shown in Table 2. The analysis revealed that
Box’s test, a test of the null hypothesis that the observed covariance matrices are equal
across groups, was not significant, Box’s M = 7.84, F(6, 11,357.49) = 1.25, p =. 277. The
overall multivariate statistic Wilks’ lambda was not significant, Wilks’ lambda = .984, F(
3, 298 ) = 1.57, p = .196, suggesting that no differences existed between the groups on
the dependent variables. As such, no further testing was justified.

Table 2
Descriptive Statistics for MBA Variables
Mean
SD
Investment in Appearance
1 2.1875
0.82022
2 2.1627
0.6708
Total 2.1653
0.68618
Investment in Body Integrity
1 2.1319
0.58397
2 2.1549
0.73486
Total 2.1525
0.72028
________________________________________________________________________
*No PBM with surveillance = 1; PBM with/with9out surveillance = 2; MBA = Measure
of Body Apperception
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Hypotheses 2a, 2b, and 2c
Hypothesis 2a predicted that women with deleterious BRCA1/2 mutations who
had undergone PBMs would display greater experiences of stigma on a measure of selfconcept compared to women with deleterious BRCA1/2 mutations who had chosen to use
surveillance methods only. Hypothesis 2b predicted that women with deleterious
BRCA1/2 mutations who had undergone PBMs would display greater experiences of
vulnerability on a measure of self-concept compared to women with deleterious
BRCA1/2 mutations who had chosen to use surveillance methods only. Hypothesis 2c
predicted that women with deleterious BRCA1/2 mutations who had undergone PBMs
would display fewer mastery experiences on a measure of self-concept compared to
women with deleterious BRCA1/2 mutations who had chosen to use surveillance
methods only.
There were two levels of the independent variable (PBM vs. no PBM with use of
surveillance methods). The dependent variables were mastery, stigma, and vulnerability.
The dependent variables were correlated as follows: stigma and vulnerability, r(302) =
.70, p = .000; stigma and mastery, r(346) = .48, p = .000; and vulnerability and mastery,
r(307) = .38, p = .000. These correlations met the assumption that the dependent
variables be correlated for use of MANOVA. The means and standard deviations by
condition are reported in Table 3. The analysis revealed that Box’s test, a test of the null
hypothesis that the observed covariance matrices are equal across groups, was not
significant, Box’s M = 12.80, F(3, 45342.82) = 4.18, p =. 006. This violates the
assumptions of MANOVA. The overall multivariate statistic Wilks’ lambda was not
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significant, Wilks’ lambda = 1, F(2, 351) = .059, p = .943, suggesting that no differences
existed between the groups on the dependent variables. As such, no further testing was
justified.

Table 3
Descriptive Statistics for BSCS Variables
Mean
SD
Stigma
1
3.2917
0.96451
2
3.8227
1.25394
Total
3.7752
1.23883
Vulnerability
1
4.2815
1.18095
2
4.7251
1.28611
Total
4.6854
1.2815
Mastery
1
2.2315
0.74976
2
2.4782
0.97059
Total
2.4561
0.9545
____________________________________________________________________
*No PBM with surveillance = 1; PBM with/without surveillance = 2; BSCS = BRCA Self
Concept Scale
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Chapter 5: Discussion
In this chapter, the significance and implications of the findings are discussed.
First, the demographic characteristics of the same are addressed. Second, the outcomes
from the hypothesis testing are reviewed in light of the literature in this area. Finally, the
implications, limitations, and recommendations for future studies are considered.
Demographic Characteristics
Overall, 358 women participated in this study. All of these women reported
having a deleterious BRCA1/2 mutation, being able to read and understand English, and
being older than the age of 18 years. The majority of the participants fell within the 35- to
44-year age range, reported being married, and reported having at least one child at home
under the age of 18 years. Almost all of the participants reported having a family history
of cancer, most prominently breast cancer and ovarian cancer, which is consistent with
BRCA1/2 families because of increased risk of these cancers. The majority of the
participants reported having previously undergone a prophylactic bilateral mastectomy
(PBM and undergoing at least one form of surveillance (e.g., breast self-exams, clinical
breast exams, magnetic resonance imaging [MRI], mammograms).
Outcome of Measures
The two groups that were compared included women who had PBMs regardless
of whether they engaged in surveillance methods or not, and women who engaged in
surveillance methods but never had a PBM. Internal consistency was found to be present
for both the Measure of Body Apperception (MBA) and BRCA Self-Concept Scale
(BSCS). In order to test the hypotheses, two separate MANOVAs were conducted. No
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significant difference was found between groups on any of the hypotheses. For the MBA,
no differences were found between groups in terms of investment in body integrity and
investment in appearance. For the BSCS, no differences were found between groups in
terms of experiences of stigma, experiences of vulnerability, and mastery experiences.
Implications of Findings
This study examined how women with deleterious BRCA1/2 mutations who
choose to undergo a PBM compare to those who use surveillance methods differ on
measures of body image and self-concept. It was hypothesized that women who chose to
undergo a PBM would display greater investment in appearance, greater investment in
body integrity, greater experiences of stigma, greater experiences of vulnerability, and
fewer mastery experiences than those who did not have a PBM and chose to undergo
surveillance methods only. Interestingly, no significant differences were found on any of
the hypotheses, meaning that the hypotheses were not supported. The many potential
explanations for finding no significant results include the possibility of the interaction
and importance of additional variables.
Paterson, Lengacher, Donovan, Kip, and Tofthagen (2016) looked at body image
in young survivors of breast cancer and found that age and type of cancer treatment had a
significant impact on body image, with poorer body image being elevated to physical and
psychological stress, sex and intimacy, and partnered relationships among younger
women. These researchers found that body image disturbance is prevalent and often
associated with other issues, such as sexual functioning, in the population of survivors of
breast cancer, particularly distressing to the younger survivor population. Body image
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disturbance in particular has the potential to cause difficulties in recovery from breast
cancer, with younger women being at a particularly high risk for this adverse effect after
treatment both because of their life stage and because of the more aggressive treatments
that are often associated with the more aggressive cancers that present in younger women
(Paterson et al., 2016). The results and findings of this study suggest that the relationship
between body image and even seemingly minute details of an individual’s treatment or
cancer journey is complex and not yet completely understood.
A study by Sherman, Woon, French, and Elder (2017) looked at women who had
specifically undergone a nipple-sparing mastectomy with immediate breast reconstruction
and found moderately low levels of psychological distress and body image disturbance
among these women. These researchers hypothesized that this particular procedure may
minimize adverse psychological impacts of mastectomy and may offer the potential for
better cosmetic outcomes and less body image disturbance compared to non-nipplesparing approaches. Sherman et al. (2017) also found that increased body image
disturbance was associated with psychological distress and moderated by selfcompassion and appearance investment. This study suggests that the specifics of the
treatment or surgery chosen by the individual or the individual’s treatment team has a
large effect on the individual. This suggestion was not specifically examined in the
current study and therefore may have affected the results.
Notari, Notari, Favez, Delaloye, and Ghisletta (2015) examined whether women’s
perceptions regarding the impact of breast cancer treatment on their bodies could be
partly determined by the quality of the relational context in which they live. These

BRCA1/2, SELF-CONCEPT, AND BODY IMAGE

77

researchers found that married women reported less body image disturbance than did
unmarried women at all points of comparison in this longitudinal study. Their results
showed that relationship satisfaction determined the level of body image disturbance
more than marital status itself, suggesting that women’s experiences of a sense of security
and of being loved may reassure them and help them better adjust to treatment-induced
physical changes (Notari et al., 2015). Thus, relationship satisfaction and support are
additional areas that may have a significant impact on both body image and self-concept.
In terms of the genetic testing itself, many authors have assumed that disclosure
of DNA test results by a genetic counselor has direct, consistent influence on many
aspects of the counselee’s life; however, Vos, Gomez-Garcia et al. (2012) found a direct
influence exists only for counselees’ decisions for surgery, which are directly predicted
by the communication of a pathogenic or uninformative DNA test result. Additionally,
Vos, Oosterwijk et al. (2012) found that the outcomes of DNA testing were better
predicted by the counselees’ perceptions than by the actual given genetic information.
This finding confirmed the importance of perception in the process of recalling and
interpreting cancer risk, as well as in making decisions about healthcare (Vos, Oosterwijk
et al., 2012). Consequently, perception may also play a significant role in various aspects
of the lives of women with BRCA1/2 mutations, possibly contributing to their body
image and self-concept and the change in these factors throughout their lives and
throughout their journey as carriers of BRCA1/2 mutations.
While each of the aforementioned studies focuses on a slightly different
population than the population in this study, the general suggestion that other variables
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may be affecting body image and self-concept remains the same. Such factors as
different relational dynamics; the specifics of surgeries and treatments; self-compassion;
and the individual’s perception of testing, genetic status, and surgeries/procedures may
affect the experience of body image and self-concept in women with BRCA1/2
mutations. In addition, those who responded to this survey might not have been
representative of the population with BRCA1/2 mutations as a whole, making the process
of studying these differences difficult, even without the possibility of additional
variables.
While no significant findings were found as a result of this study, the possible
explanations for this lack of significance can serve to help the researchers and
professionals who work with the BRCA1/2 community, as well as the BRCA1/2
community itself. In terms of the researchers who work with this community, a variety of
potential avenues of future research have been identified in terms of additional variables
that may affect the experiences that carriers of BRCA1/2 mutations have, especially in
terms of body image and self-concept. These additional variables can serve as a
springboard of ideas for future studies and may inspire others to continue examining this
particular area, as little is known about the portion of the population of those with
BRCA1/2 mutations who have undergone preventative surgeries without first
experiencing a BRCA1/2-related cancer.
In terms of the professionals who work with the BRCA1/2 community, many
different disciplines are involved: breast surgeons, plastic surgeons, primary-care
physicians, gynecologists, genetic counselors, therapists, psychologists, and more. Over
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time, the more that is learned about the complexity of the experience that carriers of
BRCA1/2 mutations go through, especially those who consider themselves previvors, the
more that these various disciplines can learn how to assess and refer patients who seem to
be struggling in different areas. Hopefully, physicians working at the front line of
preventative surgeries and other medical treatments will be able to detect carriers of
BRCA1/2 mutations who struggle with such issues as body image and self-concept and
refer these individuals to genetic counselors, therapists, or psychologists who can best
help them take care of their mental and emotional health and meet their needs in general.
With more knowledge about the inner experience of this population, genetic counselors
may be able to best identify and educate those in the genetic-testing phase of their
journeys, while therapists and psychologists may best be able to understand the
psychological makeup of this population and subsequently design interventions that may
best support them throughout their lifelong journeys as carriers of BRCA1/2 mutations.
The benefits of this study are potentially endless and life changing for the
population with BRCA1/2 mutations. If this study were to inspire researchers to continue
learning more about this particular population, and if that continued learning were to then
produce research that various mental-health and medical professionals could apply to
their work with this population, the treatment that this population would receive in
various domains would potentially improve. This study may also help the population with
BRCA1/2 mutations learn more about themselves and their experiences and help them to
become better advocates for themselves and their unmet needs. The more information
that is known about the community with BRCA1/2 mutations, the better the members of
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this community can learn to support one another, adding to the quality and efficacy of the
community as a whole.
Limitations
While this study possesses a variety of strengths, several limitations are also
evident. In terms of methodology, sample size is one limitation. Women with BRCA1/2
mutations constitute a relatively small group of individuals compared to the size of the
general population. Thus, the population used in this study is substantially smaller than
the whole population of women with BRCA1/2 mutations, suggesting that the results of
this study may not be representative of the general population. The women who chose to
participate in this study represent women with BRCA1/2 mutations who engage in online
support groups and therefore may not necessarily be representative of the entire
population of women with BRCA1/2 mutations. Additionally, this sample is
disproportionate in terms of the number of women who have chosen to undergo PBMs
versus those who have chosen surveillance methods only. Future research that focuses on
larger or more representative samples of women with BRCA1/2 mutations and is able to
find more women who have chosen surveillance methods only would be interesting.
Another methodological limitation involves the measures that were used in this
study. The MBA has not been exclusively used with women with BRCA1/2 mutations.
Additionally, the BSCS has been used only with women with BRCA1/2 mutations who
have had cancer. Thus, neither of these measures has been used with this study’s specific
population. In the future, studies should be conducted with women with BRCA1/2
mutations and these measures in an effort to provide support for the results of this study.
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Additionally, the measures used in this study were all administered online and were selfreport in nature. Self-report data are limited by the fact that they cannot be independently
verified and can contain several potential sources of bias. These limitations do not make
the findings and results of this study less meaningful. However, they do serve as points to
keep in mind when thinking about generalizability, as well as when making
interpretations and drawing conclusions about the findings.
Future Studies
Future research should more generally focus on expanding the research base on
those with BRCA1/2 mutations in an effort to continue to gather more information about
this population, their unique experiences, and the ways that their genetic predisposition
impacts their mental health and general functioning. Expanding the research base is
especially important considering that most of the research on surveillance and
mastectomies is focused on populations without BRCA1/2 breast cancer. Future research
should also examine male individuals with BRCA1/2 mutations, as this subgroup often
goes unnoticed in the research because of the smaller number of male individuals who are
aware of possessing this mutation. Specifically, in terms of self-concept and body image,
additional studies should focus on learning more about how BRCA1/2 mutations may
impact these constructs, the implications of this impact, and interventions that could be
used to help minimize any negative impact. A comparison of those who have and have
not engaged in various surgery and reconstructive efforts would help to determine if this
is a factor in both body image and self-concept, as well as to gather a more complete and
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detailed timeline of diagnosis and procedures done in an effort to discover the variables
that affect body image and self-concept for this particular population.
Future research should also make an effort to gain a more representative sample
of the population with BRCA1/2 mutations, expanding research beyond those who are
members of particular online support groups. While gaining a more representative sample
may prove difficult because of the relatively small size of this population, doing so would
allow for greater generalizability of results. These topics for future research hopefully
will pave the way to helping carriers of BRCA1/2 mutations adjust to being BRCA1/2
positive, as well as to endure the difficult life decisions and medical interventions that are
often associated with this diagnosis. In addition, psychological techniques and
interventions could be identified to help this population cope with some difficult
decisions and experiences and to help them heal, grow, and move forward with fulfilling
and meaningful lives. Gaining a better understanding of the population with BRCA1/2
mutations could help shed some light on the complexity of this population and serve to
better the services and care offered to this population moving forward.
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